0000000001330878

AUTHOR

Giovanni Savettieri

showing 306 related works from this author

Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.

2014

Objective: The objective of this paper is to identify clinical or magnetic resonance imaging (MRI) predictors of long-term clinical progression in a large cohort of multiple sclerosis (MS) patients. Methods: A total of 241 relapsing–remitting (RR) MS patients were included in a nine-year follow-up (FU) study. The reference MRIs were acquired at baseline (BL) as part of a multicenter, cross-sectional, clinical-MRI study. Volumetric MRI metrics were measured by a fully automated, operator-independent, multi-parametric segmentation method. Clinical progression was evaluated as defined by: conversion from RR to secondary progressive (SP) disease course; progression of Expanded Disability Status…

AdultMalemedicine.medical_specialtyMagnetic resonance imaging follow-up multiple sclerosis clinical predictors gray matter atrophypredictormultiple sclerosisDisease courseDisability EvaluationMultiple Sclerosis Relapsing-RemittingInternal medicinefollow-upmedicineHumansSecondary progressiveExpanded Disability Status Scalemedicine.diagnostic_testbusiness.industryMultiple sclerosisDisease progressionFollow up studiesMagnetic resonance imagingclinical predictorsMiddle Agedmedicine.diseaseMagnetic Resonance Imaginggray matter atrophyCross-Sectional StudiesNeurologymultiple sclerosiDisease ProgressionSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessNuclear medicineClinical progressionMRIFollow-Up StudiesMultiple sclerosis (Houndmills, Basingstoke, England)
researchProduct

Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability.

2007

Abstract Background Fatigue is a major problem in multiple sclerosis (MS), and its association with MRI features is debated. Objective To study the correlation between fatigue and lesion load, white matter (WM), and grey matter (GM), in MS patients independent of disability. Methods We studied 222 relapsing remitting MS patients with low disability (scores ≤ 2 at the Kurtzke Expanded Disability Status Scale). Lesion load, WM and GM were measured by fully automated, operator-independent, multi-parametric segmentation method. T1 and T2 lesion volume were also measured by a semi-automated method. Fatigue was assessed by the Fatigue Severity Scale (FSS), and patients divided in high-fatigue (FS…

AdultMalemedicine.medical_specialtyMultiple SclerosisStatistics as TopicGrey matterLesionWhite matterCentral nervous system diseaseDisability EvaluationAtrophyInternal medicinemedicineImage Processing Computer-AssistedHumansRisk factorFatigueAnalysis of VarianceBrain Mappingbusiness.industryMultiple sclerosisBrainmedicine.diseaseMagnetic Resonance ImagingSurgeryOxygenMultiple Sclerosis fatiguemedicine.anatomical_structureNeurologymultiple sclerosiFemaleNeurology (clinical)Analysis of variancemedicine.symptomAtrophybusinessbrain atrophyMRI
researchProduct

Lack of association between estrogen receptor 1 gene polymorphisms and multiple sclerosis in southern Italy in humans

2002

Estrogen receptor 1 gene polymorphisms (ESR1) have been found to be associated with multiple sclerosis (MS) in both Japanese and Finnish populations. We investigated the association between ESR1 polymorphisms (PvuII and XbaI) and MS in a study of 132 MS patients and 129 controls from the same geographic background (southern Italy). Allelic and genotypic frequencies were not different between MS patients and population controls for either the PvuII or XbaI polymorphism. This result suggests that the association between a given disease and a genomic characteristic must be confirmed by separate investigations in different populations. © 2002 Elsevier Science Ireland Ltd. All rights reserved.

AdultMaleMultiple SclerosisAdolescentGenotypePopulationEstrogen receptorBiologyGene FrequencyPolymorphism (computer science)GenotypemedicineGenetic predispositionHumansGenetic Predisposition to DiseaseAlleleeducationAgededucation.field_of_studyPolymorphism GeneticGeneral NeuroscienceMultiple sclerosisEstrogen Receptor alphaEstrogen receptor Genetic susceptibility Italians Multiple sclerosis PolymorphismMiddle Agedmedicine.diseaseItalyReceptors EstrogenImmunologyFemaleEstrogen receptor alphaNeuroscience Letters
researchProduct

High Prevalence and Fast Rising Incidence of Multiple Sclerosis in Caltanissetta, Sicily, Southern Italy

2006

<i>Background:</i> Epidemiological studies conducted in Sicily and Sardinia, the two major Mediterranean islands, showed elevated incidence and prevalence of multiple sclerosis (MS)and a recent increase in disease frequency. <i>Objective:</i> To confirm the central highlands of Sicily as areas of increasing MS prevalence and elevated incidence, we performed a follow-up study based on the town of Caltanissetta (Sicily), southern Italy. <i>Methods:</i> We made a formal diagnostic reappraisal of all living patients found in the previous study performed in 1981. All possible information sources were used to search for patients affected by MS diagnosed accordi…

AdultMalemedicine.medical_specialtyMultiple SclerosisAdolescentMultiple sclerosis incidence Prevalence SicilyEpidemiologyAge DistributionEpidemiologyPrevalencemedicineHumansSex DistributionSicilyAgedHigh prevalencebusiness.industryIncidenceMultiple sclerosisIncidence (epidemiology)Urban HealthMiddle Agedmedicine.diseaseHealth SurveyshumanitiesFemaleSettore MED/26 - NeurologiaNeurology (clinical)businessMediterranean IslandsFollow-Up StudiesDemographyNeuroepidemiology
researchProduct

TRANSCRANIAL DIRECT CURRENT STIMULATION FOR TREATMENT OF FREEZING OF GAIT IN PARKINSON’S DISEASE. A CROSS-OVER STUDY

2013

medicine.medical_specialtyParkinson's diseaseTranscranial direct-current stimulationFreezing of gaitbusiness.industrymedicine.medical_treatmentmedicine.diseaseCrossover studyGait (human)Physical medicine and rehabilitationNeurologymedicineNeurology (clinical)business
researchProduct

Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis

2004

BACKGROUND: Cognitive impairment may occur at any time during the course of multiple sclerosis (MS), and it is often a major cause of disability in patients with the disease. The APOE-epsilon4 allele is the major known genetic risk factor for late onset familial and sporadic Alzheimer's Disease (AD), and it seems to be implicated in cognitive decline in normal elderly persons. OBJECTIVE: To investigate the clinical and genetic variables that can be associated with the cognitive decline in patients with MS. METHODS: Five-hundred and three patients with clinically definite MS underwent a battery of neuropsychological tests and, according to the number of failed tests, were divided into cognit…

Apolipoprotein EAdultMalemedicine.medical_specialtyPediatricsNeurologyMultiple SclerosisMessengerLate onsetDiseaseNeuropsychological TestsApolipoproteins EmedicineOdds RatioHumansRNA MessengerCognitive declineAllelePsychiatrycognitive impairmentAPOE; Cognitive impairment; Multiple sclerosisAnalysis of VarianceSex CharacteristicsChi-Square DistributionReverse Transcriptase Polymerase Chain ReactionMultiple sclerosisCognitive disorderGenetic VariationMiddle Agedmedicine.diseasemultiple sclerosis cognitive impairment gender geneticNeurologyGenetic Variation; Odds Ratio; Analysis of Variance; Sex Characteristics; Chi-Square Distribution; Humans; Apolipoproteins E; Reverse Transcriptase Polymerase Chain Reaction; Cognition Disorders; RNA Messenger; Multiple Sclerosis; Adult; Middle Aged; Neuropsychological Tests; Female; MaleRNAFemaleSettore MED/26 - NeurologiaNeurology (clinical)Psychologymultiple sclerosis · cognitive impairment · APOECognition DisordersAPOE
researchProduct

Binding of flunitrazepam to differentiating neurons cultured in a chemically defined, hormone-supplemented medium

1990

[3H]Flunitrazepam (FNZ) binding to cortical neurons from fetal rat brain was investigated in vitro. The use of a synthetic medium specific for neurons made it possible to plot a developmental curve of3H-FNZ binding in an almost pure neuronal culture. Detectable specific binding was present in vitro at time 0 (that is, the 16th gestational day). A progressive increase of binding, due to an increment in the number of recognition sites, was observed on the subsequent days. The affinity of the specific binding sites to3H-FNZ was enhanced by the addition of exogenous GABA, whereas the density was not affected. © 1990 Plenum Publishing Corporation.

Central nervous systemFlunitrazepamBiologySettore BIO/19 - Microbiologia GeneraleBiochemistrygamma-Aminobutyric acidGABACellular and Molecular NeurosciencemedicineAnimalsBinding siteCells Culturedgamma-Aminobutyric AcidNeuronsFetusCell DifferentiationGeneral MedicineHormonesIn vitroCulture MediaCell biologymedicine.anatomical_structureneuronal cultureCell cultureCerebral cortexSettore MED/26 - NeurologiaFlunitrazepamNeurosciencemedicine.drugNeurochemical Research
researchProduct

Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease.

2008

Myocardial (123)Metaiodobenzylguanidine (MIBG) enables the assessment of postganglionic sympathetic cardiac innervation. MIBG uptake is decreased in nearly all patients with Parkinson's disease (PD). Our objective was to evaluate MIBG uptake in patients with genetic PD. We investigated MIBG uptake in 14 patients with PD associated with mutations in different genes (Parkin, DJ-1, PINK], and leucine-rich repeat kinase 2 -LRRK2), in 15 patients with idiopathic PD, and 10 control subjects. The myocardial MIGB uptake was preserved in 3 of the 4 Parkin-associated Parkinsonisms, in I of the 2 patients with DJ-1 mutations, in 1 of the 2 brothers with PINK] mutations, in 3 of the 6 unrelated patient…

AdultMalemedicine.medical_specialtyParkinson's diseaseGenotypeUbiquitin-Protein LigasesDNA Mutational AnalysisProtein Deglycase DJ-1PINK1Gene mutationProtein Serine-Threonine Kinasesmedicine.disease_causeLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Severity of Illness IndexParkinCentral nervous system diseaseDiagnosis DifferentialDegenerative diseaseParkinsonian DisordersInternal medicineSurveys and QuestionnairesmedicineHumansPoint MutationPromoter Regions GeneticGenetic PD Myocardial scintigraphyOncogene ProteinsTomography Emission-Computed Single-PhotonMutationMovement Disordersbusiness.industryMyocardiumIntracellular Signaling Peptides and ProteinsParkinson DiseaseGalvanic Skin ResponseMiddle Agedmedicine.diseaseLRRK2nervous system diseases3-IodobenzylguanidineEndocrinologyNeurologySettore MED/26 - NeurologiaFemaleNeurology (clinical)RadiopharmaceuticalsbusinessProtein KinasesMovement disorders : official journal of the Movement Disorder Society
researchProduct

Epidemiology of multiple sclerosis in Sicily

2001

From epidemiological data obtained over more than 20 years by surveys conducted in different parts of Sicily, it is evident that Sicily is a high-risk area for multiple sclerosis (MS). This is in sharp contrast with the gradient hypothesis. High frequencies have been found in different parts of the island having different geoclimatic features, but at least two cities (Monreale and Enna) had had a prolonged Norman domination. This is in agreement with the hypothesis that MS originated in Northern Europe and spread around the world throughout the raids of the northern peoples. The increase in frequency estimated by follow-up and incidence studies is well established and is only in part linked…

Malemedicine.medical_specialtyMultiple SclerosisRange (biology)PrevalenceDermatologySex FactorsRisk FactorsEpidemiologymedicinePrevalenceHumansMultiple sclerosiSicilyNeuroscience (all)Multiple sclerosisIncidence (epidemiology)IncidenceAge FactorsGeneral Medicinemedicine.diseasePsychiatry and Mental healthGeographyFemaleSettore MED/26 - NeurologiaNeurology (clinical)CartographyFollow-Up Studies
researchProduct

Brain atrophy and lesion load in a large population of patients with multiple sclerosis

2005

Objective: To measure white matter (WM) and gray matter (GM) atrophy and lesion load in a large population of patients with multiple sclerosis (MS) using a fully automated, operator-independent, multiparametric segmentation method. Methods: The study population consisted of 597 patients with MS and 104 control subjects. The MRI parameters were abnormal WM fraction (AWM-f), global WM-f (gWM-f), and GM fraction (GM-f). Results: Significant differences between patients with MS and control subjects included higher AWM-f and reduced gWM-f and GM-f. MRI data showed significant differences between patients with relapsing-remitting and secondary progressive forms of MS. Significant correlations bet…

AdultMalePathologymedicine.medical_specialtyAdolescentBrain mappingNerve Fibers MyelinatedCentral nervous system diseaseWhite matterMultiple sclerosisAtrophySex FactorsPredictive Value of TestsNeural PathwaysmedicineHumansAge of OnsetMultiple Sclerosis/physiopathologyAgedCross-Sectional StudieBrain MappingExpanded Disability Status Scalemedicine.diagnostic_testBrain/physiopathologybusiness.industryMultiple sclerosisBrainMagnetic resonance imagingInterferon-betaMiddle Agedmedicine.diseasePrognosislesion loadMagnetic Resonance ImagingMultiple Sclerosis/diagnosimedicine.anatomical_structureCross-Sectional Studiesmultiple sclerosiLinear ModelsDisease ProgressionEducational StatusFemaleNeurology (clinical)Age of onsetAtrophybusinessMultiple Sclerosis/complicationbrain atrophyMRI
researchProduct

Levetiracetam in the treatment of vascular chorea: a case report

2004

PharmacologyLevetiracetam Hemichoreabusiness.industryPharmacology toxicologyChoreaGeneral MedicineBioinformaticsMedicinePharmacology (medical)Levetiracetammedicine.symptombusinessAdverse effectmedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct

Impact of sociodemographic characteristics on cognitive performance in an elderly Sicilian population.

2002

<i>Objective:</i> To assess cognitive levels in an elderly Sicilian population and to evaluate the role of education and other sociodemographic characteristics in cognitive performance. <i>Background:</i> The pattern of cognitive performance in the elderly has not been investigated extensively in well-defined Italian populations. This study was conducted as part of a door-to-door survey of common neurologic disorders (the Sicilian Neuro-Epidemiologic Study project). <i>Methods:</i> Thirteen physicians administered an Italian version of the Short Portable Mental Status Questionnaire (SPMSQ) to all subjects aged 50 years or older who, on November 1, 1987, r…

GerontologyMaleMental Status ScheduleMultivariate analysisPsychometricsPsychometricsCross-sectional studyEpidemiologyPopulationSociodemographic characteristicDoor-to-door surveyAlzheimer DiseaseRisk FactorsMedicineHumansEffects of sleep deprivation on cognitive performanceeducationSicilyAgedAged 80 and overeducation.field_of_studybusiness.industryCognitionMiddle Agedmedicine.diseaseCognitive impairmentCross-Sectional StudiesSocioeconomic FactorsSicilian Neuro-Epidemiologic Study projectEducational StatusSettore MED/26 - NeurologiaFemaleNeurology (clinical)Alzheimer's diseasebusinessCognition DisordersMental Status ScheduleNeuroepidemiology
researchProduct

Stroke in the young in sicily: Prevalence and clinical features

1998

Few epidemiological reports focus on the prevalence of stroke in the young population. As part of a neuroepidemiological survey on the total population of three Sicilian municipalities, we assessed the prevalence of stroke in the young, describing the clinical features of each patient. We screened 14,832 subjects younger than 40 years with a door-to-door method and a two-phase study design. Phase 1 consisted of a questionnaire and a brief neurological examination; phase 2 was an extensive evaluation performed by a neurologist. On the prevalence day (November 1, 1987), we ascertained six cases of stroke (prevalence rate, 40.5/100,000). Three were hemorrhagic, one ischemic, and two of uncerta…

Pediatricsmedicine.medical_specialtymedicine.diagnostic_testbusiness.industryEpidemiologyRehabilitationPrevalenceYoungNeurological examinationTotal populationmedicine.diseaseStrokeAcquired immunodeficiency syndrome (AIDS)Young populationEpidemiologymedicinePrevalenceMotor recoverySurgerySettore MED/26 - NeurologiaNeurology (clinical)businessCardiology and Cardiovascular MedicineStroke
researchProduct

A case-control study of amyotrophic lateral sclerosis

1991

A retrospective case-control study was conducted using 46 patients affected by amyotrophic lateral sclerosis and 92 closely matched healthy controls. Cases were ascertained through typical clinical and instrumental findings. Putative risk factors (bone fractures or major trauma, exposure to domestic animals, surgical operations, disease among first degree relatives and others) were investigated anamnestically using a standard questionnaire. Using Mantel-Haenzsel estimates of the odds ratio, no association was found between amyotrophic lateral sclerosis and the investigated variables.

Malemedicine.medical_specialtyEpidemiologybusiness.industryAmyotrophic Lateral SclerosisCase-control studyRetrospective cohort studyDiseaseOdds ratiomedicine.diseasePhysical medicine and rehabilitationItalyRisk FactorsCase-Control StudiesInternal medicinemedicineHumansFemaleSettore MED/26 - NeurologiaNeurology (clinical)First-degree relativesAmyotrophic lateral sclerosisbusinessRetrospective Studies
researchProduct

Teaching Research Methods to Young Neurologists: The Erice International Courses.

2022

No

NeurologyEpidemiologyTeachingNeurology (clinical)Journal of movement disorders
researchProduct

Clinical features and lifestyle of patients with amyotrophic lateral sclerosis in Campania: brief overview of an Italian database

2012

Background. Physical activity and occupational exposures appeared to play a relevant role in pathogenesis of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease of unknown origin. Materials and methods. We aimed to make an overview of the clinical characteristics and life - style (occupation and sport) of a population of 395 patients with ALS from campania, in southern Italy. Results. ALS onset resulted anticipated of about 11 years in industry workers, whilst the more frequent site of onset among farmers was upper limbs. compared to non-athletes, athletes, particu- larly soccer players, showed a 7 years anticipation of ALS onset, with higher mortality after 5 years. Discussion…

Malesclerosi laterale amiotroficaDatabases Factualesposizione occupazionaleOccupational ExposureHumansMedicineOccupationsAmyotrophic lateral sclerosisLife Styledatabase clinicoAgedLife stylebusiness.industrylcsh:Public aspects of medicineAmyotrophic Lateral SclerosisDisease progressionPublic Health Environmental and Occupational Healthlcsh:RA1-1270General MedicineMiddle Agedmedicine.diseaseItalyDisease ProgressionAmyotrophic lateral sclerosis motor neuron diseases clinical database occupational exposure.Settore MED/26 - NeurologiaFemaleOccupational exposurebusinessmalattie del motoneuroneHumanitiesSportsAnnali dell'Istituto Superiore di Sanità
researchProduct

Population-based case-control study of essential tremor.

1998

Current epidemiologic data on the association between environmental factors and essential tremor (ET) are scanty. In a population-based case-control study we investigated the relationship between some putative risk factors and ET. In the present study, we included all subjects identified during a door-to-door prevalence survey in a Sicilian community, affected by ET, and alive on 1 November 1987 (n=31). Of the 31 prevalent cases of ET, we were able to contact 28 subjects. Twenty-eight controls were randomly selected from the general population and matched to each case for age and sex. Exposure variables were investigated by interviewing the patients and their controls or close relatives, us…

AdultMalemedicine.medical_specialtyPathologyEpidemiologyEssential TremorPopulationDermatologyPopulation basedOddsRisk FactorsEpidemiologymedicinePrevalenceHumanseducationAgedAged 80 and overeducation.field_of_studyNeuroscience (all)Essential tremorbusiness.industryGeneral NeuroscienceCase-control studyCase-control studyGeneral MedicineEnvironmental exposureEnvironmental ExposureMiddle Agedmedicine.diseasePsychiatry and Mental healthCase-Control StudiesSettore MED/26 - NeurologiaFemaleNeurology (clinical)Epidemiologic databusiness2708DemographyItalian journal of neurological sciences
researchProduct

A population-based survey of cognitive performance in a Sicilian elderly community.

2010

<i>Background:</i> The global burden of neurodegenerative diseases is increasing. Previous studies reported differences related to age, gender and socioeconomic status. We calculated the cognitive performances of a Sicilian population aged 65 years or older, by means of a door-to-door population-based survey in Bagheria city, Sicily. <i>Methods:</i> A door-to-door survey was carried out in the city of Bagheria, Sicily (prevalence day September 30, 2006). A cohort of 2,200 persons was randomly stratified, obtaining a 25% sample of the whole population. Cognitive function was assessed by Mini Mental State Examination (MMSE). Percentile distributions by age, gender, edu…

GerontologyMalePercentileEpidemiologySurvey population-basedPopulationCohort StudiesCognitionResidence CharacteristicsmedicineDementiaHumanseducationCognitive performanceSocioeconomic statusSicilyAgedAged 80 and overeducation.field_of_studyMini–Mental State Examinationmedicine.diagnostic_testbusiness.industryAge FactorsCognitionRegression analysismedicine.diseaseItalyPopulation SurveillanceCohortFemaleDementiaSettore MED/26 - NeurologiaNeurology (clinical)businessCognition DisordersMental Status Schedule
researchProduct

Stroke incidence and survival in three Sicilian municipalities

1998

We investigated the incidence of first-ever stroke in three Sicilian municipalities over the years 1984–1987. Case ascertainment involved two approaches: a doorto-door two-phase prevalence survey and a study of death certificates. Only first-ever strokes occurring within the study time interval were included, and diagnoses were based on specified criteria. We found 138 subjects who had experienced a first stroke over 73 488 person-years; the average incidence rate (new cases per 1000 population per year) was 1.9 overall, 1.7 in men, and 2.1 in women. Incidence increased steeply with age and was similar in men and women. Incidence was similar in the three study municipalities. The overall ca…

medicine.medical_specialtyPediatricsNeurologySurvivalEpidemiologyPopulationEpidemiologyMedicineeducationSicilyStrokeNeuroradiologyeducation.field_of_studyNeuroscience (all)business.industryIncidenceGeneral NeuroscienceIncidence (epidemiology)medicine.diseaselanguage.human_languageStrokeItalyPsychiatry and Mental HealthlanguageSettore MED/26 - NeurologiaNeurology (clinical)businessStroke incidenceSicilian2708
researchProduct

Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study

2009

Background To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load and atrophy evolution, and the relationship between clinical and magnetic resonance imaging (MRI) correlates of disease progression. Methods Two hundred and sixty-seven patients with MS were studied at baseline and two years later using the same MRI protocol. Abnormal white matter fraction, normal appearing white matter fraction, global white matter fraction, gray matter fraction and whole brain fraction, T2-hyperintense, and T1-hypointense lesions were measured at both time points. Results The majority of patients were clinically stable, whereas MRI-derived brain tissue fractions were signifi…

AdultMalePathologymedicine.medical_specialtyAdolescentCentral nervous systemmultiple sclerosisSeverity of Illness IndexLesion loadWhite matterCentral nervous system diseaseYoung AdultDegenerative diseaseAtrophyMultiple Sclerosis Relapsing-RemittingatrophyRisk FactorsT2 lesionsmedicinefollow upHumansAgedmedicine.diagnostic_testbusiness.industryMultiple sclerosisBrain AtrophyBrainMagnetic resonance imagingMiddle AgedMultiple Sclerosis Chronic Progressivelesion loadmedicine.diseaseMagnetic Resonance Imagingmedicine.anatomical_structureCross-Sectional StudiesLogistic ModelsNeurologymultiple sclerosiMultivariate AnalysisDisease ProgressionFemaleSettore MED/26 - NeurologiaNeurology (clinical)businessFollow-Up StudiesMRI
researchProduct

Incidence and lifetime prevalence of Bell's palsy in two Sicilian municipalities

1996

Introduction - In a door-to-door two-phase survey of common neurologic diseases conducted in two Sicilian municipalities, we investigated the incidence and the lifetime prevalence of Bell's palsy (BP). Material & methods - During phase 1, we administered a screening instrument for facial palsy to 11,901 adult persons. During phase 2, study neurologists using specified diagnostic criteria evaluated those subjects who screened positive. Results - We found 73 subjects who had experienced BP during their life. The lifetime prevalence as of November 1, 1987, was 642.8 cases per 100,000 population age 15 years and above. The prevalence increased with age and was similar in men and women. Eighteen…

medicine.medical_specialtyeducation.field_of_studyPalsybusiness.industryIncidence (epidemiology)PopulationPrevalenceGeneral Medicinemedicine.diseaseFacial paralysisSurgeryNeurologyEpidemiology: Incidence:lifetime prevalenceEpidemiologyBell's palsymedicineCranial nerve diseaseBell's palsySettore MED/26 - NeurologiaNeurology (clinical)medicine.symptomeducationbusinessDemography
researchProduct

Dropped head as an unusual presenting sign of myasthenia gravis.

2007

Prominent or isolated weakness of cervical extensor muscles is a relatively rare clinical sign. Commonly, this is known as "dropped-head syndrome". This abnormal flexion of the head may occur in a variety of neuromuscular diseases and in a few non-neurological disorders as well. The case we describe concerns a 61-year-old woman with dropped-head syndrome as the unique complaint of myasthenia gravis.

medicine.medical_specialtyWeaknessNeurologyAbnormal flexionDermatologyNeck MusclesMyasthenia GravismedicineHumansNeuroradiologyMuscle Weaknessbusiness.industryGeneral MedicineRecovery of FunctionMiddle Agedmedicine.diseaseDermatologyMagnetic Resonance ImagingMyasthenia gravisPsychiatry and Mental healthTreatment OutcomeDropped headCervical VertebraeFemaleNeurology (clinical)NeurosurgeryCholinesterase Inhibitorsmedicine.symptombusinessHeadSign (mathematics)Pyridostigmine BromideNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily.

2007

Abstract Objective To estimate prevalence of Parkinson's disease (PD) and other types of parkinsonism in the Aeolian Archipelago, Sicily. Methods We studied the frequency of PD and other types of parkinsonism in the Aeolian Archipelago (population 13,431). All potential cases were identified from available medical information sources. To ensure the completeness of the case-findings, a screening questionnaire was also mailed to residents aged 40 years and over. Subjects were considered prevalent if they fulfilled the SNES diagnostic criteria for PD, on prevalence day (January 1, 2001). Results We identified 17 patients with parkinsonism from medical sources, and 4 from mail-survey. Prevalenc…

AdultMalePediatricsmedicine.medical_specialtyParkinson's diseasePopulationMedical informationDiseaseSeverity of Illness IndexParkinsonian DisordersEpidemiologyEpidemiology parkinsonism prevalencemedicineHumanseducationSicilyAeolian archipelagoAgedAged 80 and overeducation.field_of_studybusiness.industryParkinsonismParkinson DiseaseMiddle Agedmedicine.diseaseHealth SurveysScreening questionnaireNeurologyPhysical therapyFemaleNeurology (clinical)Geriatrics and GerontologybusinessParkinsonismrelated disorders
researchProduct

Cholesterol levels and risk of hemorrhagic transformation after acute ischemic stroke.

2011

<i>Background:</i> The association between cholesterol levels and hemorrhagic transformation (HT) is still controversial. Studies investigating this issue are influenced by treatments as some are characterized by a higher risk of HT. The aim of our study was to evaluate, in a hospital-based series of patients not treated with thrombolysis, the relationship between cholesterol levels and HT. <i>Methods:</i> We retrospectively collected information about total cholesterol (TC) and low-density lipoprotein cholesterol (LDLC) levels at admission in a consecutive series of 240 patients with anterior ischemic stroke (IS). The TC and LDLC levels were arranged in 3 groups acc…

Malemedicine.medical_specialtyDown-RegulationRisk AssessmentBrain Ischemiachemistry.chemical_compoundRisk FactorsCholesterol levels hemorrhagic transformationInternal medicinemedicineOdds RatioHumansRisk factorAcute ischemic strokeAgedRetrospective StudiesChi-Square Distributionbusiness.industryCholesterolCholesterol LDLPrognosisStrokeTransformation (genetics)CholesterolLogistic ModelsNeurologychemistryItalyIschemic strokePhysical therapyCardiologyDisease ProgressionSettore MED/26 - NeurologiaFemaleNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessIntracranial HemorrhagesBiomarkersCerebrovascular diseases (Basel, Switzerland)
researchProduct

Insidious onset of Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease

2014

N.A.

RasagilineN.A.medicine.medical_specialtyNeurologyParkinson's diseasebusiness.industryDermatologyGeneral Medicinemedicine.diseaseInsidious onsetPsychiatry and Mental healthchemistry.chemical_compoundchemistrymedicineNeurology (clinical)NeurosurgerybusinessPsychiatryNeuroradiology
researchProduct

Rat CNS cell culture. Enhancement of neuronal survival and delay of glial proliferation by serum from patients with multiple sclerosis. A morphologic…

1984

The addition of serum from multiple sclerosis (MS) patients to the culture medium of dissociated cells from cerebral hemispheres of rat embryos caused a delay in glial proliferation and an enhancement of neuronal survival. Sera from normal individuals and patients with other neurological diseases failed to show this effect. These morphological observations are interpreted as the outcome of inhibition of in vitro gliogenesis.

Central Nervous Systemmedicine.medical_specialtyPathologyNeurologyMultiple SclerosisDermatologyBiologyGliotoxinmedicineAnimalsCells CulturedGliogenesisNeuronsGeneral NeuroscienceMultiple sclerosisEmbryoCell DifferentiationGeneral MedicineMycotoxinsmedicine.diseaseEmbryo MammalianIn vitroRatsPsychiatry and Mental healthCell cultureOrgan SpecificityImmunologyNeurology (clinical)NeurogliaItalian journal of neurological sciences
researchProduct

Inhibition of glial proliferation in vitro by serum from patients with multiple sclerosis

1987

Primary cell cultures from fetal rat CNS have been employed to evaluate the effects caused by the addition of serum from patients affected by multiple sclerosis (MS). MS-serum supplemented media caused a decrease in [3H]-thymidine incorporation into the cultures, thus indicating an inhibitory effect on proliferating glial cells. Sera from patients in remission stage of the disease showed an inhibitory effect not significatively lower than those from patients in acute stage. These results suggest that glial cells may be a target of circulating factors present in MS.

AdultMalemedicine.medical_specialtyPathologyMultiple SclerosisDiseaseBiologyTritiumSettore BIO/19 - Microbiologia GeneraleInternal medicineSettore BIO/10 - BiochimicamedicineAnimalsHumansCells CulturedFetusNeuroscience (all)Cell growthMultiple sclerosisGeneral MedicineMiddle Agedmedicine.diseaseIn vitroAcute stageRatsEndocrinologymedicine.anatomical_structureNeurologyCell cultureNeurogliaFemaleSettore MED/26 - NeurologiaNeurology (clinical)NeurogliaCell DivisionThymidine
researchProduct

Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients

2015

Background: Magnetic Resonance Imaging (MRI) techniques provided evidences into the understanding of cognitive impairment (CIm) in Multiple Sclerosis (MS). Objectives: To investigate the role of white matter (WM) and gray matter (GM) in predicting long-term CIm in a cohort of MS patients. Methods: 303 out of 597 patients participating in a previous multicenter clinical-MRI study were enrolled (49.4% were lost at follow-up). The following MRI parameters, expressed as fraction (f) of intracranial volume, were evaluated: cerebrospinal fluid (CSF-f), WM-f, GM-f and abnormal WM (AWM-f), a measure of lesion load. Nine years later, cognitive status was assessed in 241 patients using the Symbol Dig…

EMTREE medical terms: Articlerecalllcsh:MedicineAudiologyNeuropsychological TestsNerve Fibers Myelinated030218 nuclear medicine & medical imagingCohort Studies0302 clinical medicinecognitive defectnuclear magnetic resonance imaginglcsh:ScienceModified Card Sorting TestMultidisciplinaryneuroimagingSemantically Related Word List TestMultiple Sclerosis Cognitive Dysfunction MRImedicine.diagnostic_testpredictive valueBrainCognitionNeuropsychological testgray matterMiddle AgedPrognosisMagnetic Resonance ImagingMemory Short-Termfemalebrain sizemultiple sclerosiCohortDisease ProgressionSettore MED/26 - Neurologiawhite matterResearch ArticleAdultmedicine.medical_specialtyMultiple SclerosisPaced Auditory Serial Addition Testverbal memorycerebrospinal fluidworking memory03 medical and health sciencesmalemedicineHumanscontrolled studyhumanRecallbusiness.industryMultiple sclerosislcsh:RMagnetic resonance imagingmedicine.diseasemajor clinical studyattentionexecutive functionSymbol Digit Modalities TestPaced Auditory Serial Addition Testneuropsychological testlcsh:QVerbal memorybusinessCognition Disorders030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease

2003

<i>Objective:</i> To investigate the association between cigarette smoking, alcohol drinking, coffee consumption and Parkinson’s disease (PD). <i>Methods:</i> We selected subjects affected by idiopathic PD, with a Mini-Mental State Examination of ≧24, and controls matched 1 to 1 with cases by age (± 2 years) and sex. Controls were randomly selected from the resident list of the same municipality of residence of the cases. We assessed cigarette smoking, alcohol drinking, and coffee consumption preceding the onset of PD or the corresponding time for controls using a structured questionnaire, which also evaluated the duration and dose of exposure. Using conditional logi…

AdultMalemedicine.medical_specialtyParkinson's diseaseAlcohol DrinkingEpidemiologyParkinson's diseaseAlcoholCoffee consumptionDiseaseNeuropsychological TestsCoffeechemistry.chemical_compoundCigarette smokingEnvironmental healthEpidemiologymedicineOdds RatioHumansCigaretteAgedAged 80 and overbusiness.industrySmokingCase-control studyParkinson DiseaseOdds ratioMiddle Agedmedicine.diseasechemistryItalyRisk factorsCase-Control StudiesRegression AnalysisFemaleNeurology (clinical)businessAlcohol
researchProduct

Transcranial direct current stimulation for treatment of freezing of gait: A cross-over study

2014

Background and objective Progression of Parkinson's disease (PD) is frequently characterized by the occurrence of freezing of gait (FOG) representing a disabling motor complication. We aim to investigate safety and efficacy of transcranial direct current stimulation of the primary motor cortex of PD patients with FOG. Methods In this cross-over, double-blind, sham-controlled study, 10 PD patients with FOG persisting in “on” state underwent anodal and sham direct current stimulation for 5 consecutive days. Clinical assessment over a 1-month period was performed. Results A significant improvement of gait, as assessed by the Stand Walk Sit test, with reduction in number and duration of FOG epi…

medicine.medical_specialtyParkinson's diseasegenetic structuresTranscranial direct-current stimulationmedicine.medical_treatmentStimulationmedicine.diseaseGaitPhysical medicine and rehabilitationmedicine.anatomical_structureNeurologyBrain stimulationBasal gangliamedicinePhysical therapyNeurology (clinical)Primary motor cortexPsychologyMotor cortexMovement Disorders
researchProduct

Diabetic and non-diabetic subjects with ischemic stroke: Differences, subtype distribution and outcome

2008

Abstract Background and aim Diabetes mellitus increases the risk of stroke, and pathophysiological changes of diabetic cerebral vessels may differ in comparison with non-diabetic ones; nonetheless, the clinical and prognostic profile of stroke in diabetic patients is not yet fully understood. On this basis, the aim of our study was to evaluate cerebrovascular risk factor prevalence in diabetic stroke patients in comparison with non-diabetics, to analyze whether diabetics have a different prevalence of stroke subtypes as classified by the TOAST classification, and determine whether diabetics and non-diabetics have a different prognosis. Methods and results We enrolled 102 diabetics and 204 n…

MaleTOAST ClassificationTime FactorsSettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Severity of Illness IndexBrain IschemiaRecurrenceRisk FactorsOdds RatioPrevalenceMedicineStrokeAged 80 and overNutrition and Dieteticsdiabetes mellituMiddle AgedPrognosisStrokeAcute DiseaseHypertensionCardiologyFemaleSettore MED/26 - NeurologiaCardiology and Cardiovascular Medicinemedicine.medical_specialtyLacunar strokeRisk AssessmentDiabetes ComplicationsTOAST classificationDiabetes mellitusInternal medicineSeverity of illnessischemic strokeHumanscardiovascular diseasesAgedbusiness.industryCase-control studyRecovery of FunctionOdds ratiomedicine.diseaseSSS*Logistic ModelsDiabetes Mellitus Type 2Case-Control StudiesPhysical therapyScandinavian Stroke ScalebusinessFollow-Up Studies
researchProduct

Neuronal cell cultures: A tool for investigations in developmental neurobiology

1992

The aim of this review is to describe environmental requirements for survival of neuronal cells in culture, and secondly to survey the complex interplay between hormones, neurotrophic factors, transport- and extracellular matrix- proteins, which characterize the developmental program of differentiating neurons. An overall reconsideration of the literature in this vast field is above the limits of the present paper; since progress and refinement in the techniques of neuronal cell cultures have paralleled the advancement in Developmental Neurobiology, we will run instead through the main steps which form the conceptual framework of neuronal cell cultures. © 1992 Plenum Publishing Corporation.

Cell Survivalhormone supplemented-serum free-mediaBiologyBiochemistryExtracellular matrixCellular and Molecular NeuroscienceNeurobiologyNeurotrophic factorsSettore BIO/10 - BiochimicamedicineAnimalsHumansGrowth SubstancesDevelopmental neurobiologybookCells CulturedNeuronsNeuroscience (all)Cell DifferentiationGeneral MedicineCulture Mediamedicine.anatomical_structureCell cultureNeuronal cell culturebook.journalSettore MED/26 - NeurologiaNeuronNeuroscienceNeurochemical Research
researchProduct

Inferior altitudinal hemianopia associated with a tumor in the posterior fossa: report of a case

1984

Altitudinal hemianopias may be related to chiasmatic involvement. A case in which horizontal inferior hemianopia is associated with a tumor in the posterior fossa producing a triventricular hydrocephalus is described. The visual field defect is interpreted as a consequence of the pressure by a dilated third ventricle upon the chiasmatic area.

Adultmedicine.medical_specialtyPosterior fossaOptic chiasmDermatologyHumansDilated third ventricleMedicineNeuroradiologyAltitudinal hemianopiaBrain Neoplasmsbusiness.industryNerve Compression SyndromesGeneral NeuroscienceGeneral MedicineAnatomyHemianopiasmedicine.diseaseeye diseasesVisual fieldSurgeryHydrocephalusPsychiatry and Mental healthmedicine.anatomical_structureCranial Fossa PosteriorOptic ChiasmHemianopsiaFemaleNeurology (clinical)businessThe Italian Journal of Neurological Sciences
researchProduct

Corticobasal syndrome-like variant of Creutzfeldt–Jakob disease: clinical description of two cases

2014

medicine.medical_specialtyNeurologymedicine.diagnostic_testbusiness.industryMEDLINEDermatologyGeneral MedicineDiseasecreutzfeldt-jakob diseasePsychiatry and Mental healthPositron emission tomographymedicineSettore MED/26 - NeurologiaNeurology (clinical)NeurosurgeryRadiologybusinessalien limbNeuroradiologyNeurological Sciences
researchProduct

A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population

2003

We have systematically screened the genome for evidence of linkage disequilibrium (LD) with multiple sclerosis (MS) by typing 6000 microsatellite markers in case-control and family based (AFBAC) cohorts from the Italian population. DNA pooling was used to reduce the genotyping effort involved. Four DNA pools were considered: cases (224 Italian MS patients), controls (231 healthy Italians), index (185 index cases from trio families) and parents (the 370 parents of the patient included in the Index pool), respectively. After refining analysis of the most promising 14 markers to emerge from this screening process, only marker D2S367 retained evidence for association. © 2003 Elsevier B.V. All r…

MaleLinkage disequilibriumMultiple SclerosisGenotypeInternational CooperationImmunologyBiologyGenomeLinkage DisequilibriumWhole genome linkage disequilibriumGene FrequencyGenotypemedicineHumansImmunology and AllergyGenetic Predisposition to DiseaseMultiple sclerosiGenetic TestingGenotypingAllele frequencyAllelesGenetic testingGeneticsmedicine.diagnostic_testGenome HumanRacial GroupsDNA poolMicrosatelliteSettore BIO/18 - GeneticaItalyNeurologyCase-Control StudiesMicrosatelliteHuman genomeFemaleSettore MED/26 - NeurologiaNeurology (clinical)Microsatellite Repeats
researchProduct

Answer to: The possible risk of cancer in multiple sclerosis patients: a controversial issue

2010

medicine.medical_specialtyMultiple Sclerosis | Demyelinating Diseases | concentric sclerosisNeurologybusiness.industryMultiple sclerosisPhysical therapyMedicineCancerSettore MED/26 - NeurologiaNeurology (clinical)businessIntensive care medicinemedicine.diseaseEuropean Journal of Neurology
researchProduct

Triiodothyronine-Induced Shortening of Chromatin Repeat Length in Neurons Cultured in a Chemically Denned Medium

1987

Abstract: At the time of terminal differentiation, mammalian cortical neurons undergo a dramatic change in the structural organization of their chromatin: the nucleosomal repeat length shortens from ∼200 base pairs in fetuses to a value of 165 base pairs after birth. These events occur several days after the end of neuronal proliferation. Previously, we reported that rat cortical neurons cultured in a very selective synthetic medium were not yet programmed to these events at the end of mitotic cycles. Herein, we report that addition of triiodothyronine to neuronal cultures induces a shortening of the chromatin repeat length comparable to the natural one. Copyright © 1987, Wiley Blackwell. A…

Neuronal terminal differentiationTime FactorsCellular differentiationBiologySettore BIO/19 - Microbiologia GeneraleChromatin structureBiochemistryCellular and Molecular NeuroscienceSettore BIO/10 - BiochimicamedicineAnimalsNucleosomeMitosisCells CulturedCerebral CortexNeuronsGeneticsNucleosomal Repeat LengthTriiodothyronineDNAChromatinCulture MediaRatsChromatinCell biologyChemically denned medium)Chemically defined mediummedicine.anatomical_structurenervous systemTriiodothyronineSettore MED/26 - NeurologiaNeuronJournal of Neurochemistry
researchProduct

Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis

2006

Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However, in the literature there are inconsistent reports on the prevalence of cognitive dysfunction, and separate data for the relapsing-remitting (RR) type of the disease are not always presented. In this study, we submitted 461 RRMS patients to a battery of neuropsychological tests to investigate their impairment in various cognitive domains. As a consequence of the exclusion criteria, the sample is not fully representative of the entire population of RRMS patients. In this selected sample, when only the eight scores of a core battery (Mental Deterioration Battery) were considered (with respectiv…

Adult050103 clinical psychologymedicine.medical_specialtyMultiple Sclerosismultiple sclerosis cognition single digit modality test information processingNeuropsychological TestsAudiologyDevelopmental psychology03 medical and health sciencesCognitionMultiple Sclerosis Relapsing-Remitting0302 clinical medicineMemoryOutpatientsOutpatients; Humans; Patient Selection; Multiple Sclerosis Relapsing-Remitting; Cognition; Cognition Disorders; Italy; Demography; Memory; Adult; Language; Neuropsychological Tests; SpeechmedicineHumansSpeech0501 psychology and cognitive sciencesMemory disorderCognitive deficitDemographyLanguagemedicine.diagnostic_testPatient SelectionMemoriaMultiple sclerosiscognition impairment05 social sciencesCognitive disorderNeuropsychologyCognitionNeuropsychological testmedicine.diseaserelapsing-remittingItalyinformation processing speedNeurologymultiple sclerosiSettore MED/26 - NeurologiaNeurology (clinical)medicine.symptomCognition DisordersPsychology030217 neurology & neurosurgeryrelapsing remitting
researchProduct

Cellular mechanism of action of thyroid hormones.

1987

Abstract It has emerged in the last decade that the molecular mechanism of action of thyroid hormones resembles that of steroids; thyroid hormones indeed exert their effects mainly by directly regulating gene expression, on association with specific chromatin-bound receptors. Of the two thyroid hormones, thyroxine (T4) appears to be a sort of prohormone, whereas triiodothyronine (T3) seems to be the active form; in this respect, T4-deiodination, which occurs at the level of the target tissues, may be crucial in the local homeostasis of T3. Moreover, many cellular compartments, other than the nucleus, can bind thyroid hormone, and at least some of these further sites might play some role in …

Cancer Researchmedicine.medical_specialtyThyroid HormonesTriiodothyronineReceptors Thyroid HormoneProhormoneThyroidCell BiologyBiologyChromatinEndocrinologymedicine.anatomical_structureMechanism of actionGene Expression RegulationInternal medicinemedicineAnimalsmedicine.symptomReceptorMolecular BiologyCellular compartmentDevelopmental Biologymedicine.drugHormoneDifferentiation; research in biological diversity
researchProduct

Prevalence of Parkinson's disease and other types of parkinsonism: A door-to-door survey in three Sicilian municipalities

1992

We investigated the prevalence of Parkinson's disease and other types of parkinsonism in a Sicilian population using a door-to-door two-phase approach. This design called for the administration of a brief screening instrument to all subjects who, on November 1, 1987, were residents of Terrasini (Palermo Province), Santa Teresa di Riva (Messina Province), and Riposto (Catania Province), Sicily (N = 24,496). Study neurologists using specified diagnostic criteria extensively investigated those subjects who screened positive. We found 63 subjects affected by Parkinson's disease, 21 with secondary parkinsonism, and seven with unspecified parkinsonism. The crude prevalence per 100,000 population …

medicine.medical_specialtyeducation.field_of_studyParkinson's diseasebusiness.industryParkinsonismPopulationDiseasemedicine.diseaselanguage.human_languagenervous system diseasesDegenerative diseaseEpidemiologymedicinelanguageNeurology (clinical)businesseducationSicilianMass screeningDemographyNeurology
researchProduct

Oligodendroglioma cells shed microvesicles which contain TRAIL as well as molecular chaperones and induce cell death in astrocytes.

2011

Microvesicles (MVs) shed from G26/24 oligodendroglioma cells were previously reported to cause a reproducible, dose-dependent, inhibitory effect on neurite outgrowth, and eventually neuronal apoptosis, when added to primary cultures of rat cortical neurons. These effects were reduced but not abolished by functional monoclonal antibodies against Fas-L. In order to investigate whether MVs contain other factors able to induce cell death, we tested them for TRAIL and found clear evidence of its presence in the vesicles. This finding suggests the possibility that Fas-L and TRAIL cooperate in inducing brain cell death. Aimed at understanding the route through which the vesicles deliver their mess…

Cancer ResearchProgrammed cell deathNeuritemedicine.drug_classOligodendrogliomaCellCell CommunicationBiologyMonoclonal antibodyTNF-Related Apoptosis-Inducing LigandCell-Derived MicroparticlesmedicineAnimalsHSP70 Heat-Shock ProteinsRats WistarCells CulturedCell DeathVesicleHSC70 Heat-Shock ProteinsCell cycleMicrovesiclesRatsCell biologymedicine.anatomical_structureOncologyApoptosisAstrocytesCulture Media Conditionedmicrovesicles oligodendroglioma astrocytes TRAIL Hsp70Molecular Chaperones
researchProduct

VALIDATING SCREENING INSTRUMENTS FOR NEUROEPIDEMIOLOGIC SURVEYS - EXPERIENCE IN SICILY

1992

In a hospital setting in Sicily, we assessed a screening instrument developed for a prevalence survey of parkinsonism, peripheral neuropathies, stroke, and epilepsy. The subjects consisted of (1) hospital patients with any of the above-mentioned diseases, to investigate sensitivity; and (2) hospital visitors free of all these diseases, to investigate specificity. The standard for comparison was a clinical evaluation based on specified criteria. Trained interviewers administered the screening instrument, asking subjects to answer symptom questions and to perform simple physical tasks. For the questions and tasks together, the sensitivity estimates were 100% for parkinsonism (n = 21), 96% for…

medicine.medical_specialtyEpidemiologybusiness.industryParkinsonismPublic healthTest validityPrevalence surveymedicine.diseaseEpilepsyEpidemiologymedicinePhysical therapybusinessStrokeScreening instrument
researchProduct

Frequency and determinants for hemorrhagic transformation of posterior cerebral stroke : Posterior ischemic stroke and hemorrhagic transformation.

2017

BACKGROUND: hemorrhagic transformation is a threatening ischemic stroke complication. Frequency of hemorrhagic transformation differs greatly among studies, and its risk factors have been usually studied in patients with anterior ischemic stroke who received thrombolytic therapy. We evaluated, in a hospital-based series of patients with posterior ischemic stroke not treated with thrombolysis, frequency and risk factors of hemorrhagic transformation. Patients with posterior circulation stroke were seen in our Department during the period January 2004 to December 2009. Demographic and clinical information were collected. We estimated risk for spontaneous hemorrhagic transformation by means of…

medicine.medical_specialtymedicine.medical_treatmentCerebral strokeLogistic regressionGeneral Biochemistry Genetics and Molecular BiologyBrain ischemia03 medical and health sciences0302 clinical medicineInternal medicineEpidemiologymedicinebiochemistry030212 general & internal medicineStrokebusiness.industryposterior ischemic strokegenetics and molecular biology (all)epidemiology; hemorrhagic transformation; posterior ischemic stroke; biochemistry genetics and molecular biology (all)General MedicineThrombolysismedicine.diseaseSurgeryhemorrhagic transformationIschemic strokeCardiologyepidemiologyComplicationbusiness030217 neurology & neurosurgery
researchProduct

Prevalence of lumbosacral radiculopathy in two Sicilian municipalities

2009

Objectives - As part of a door-to-door survey of neurologic diseases, we investigated the prevalence of lumbosacral radiculopathy (LR) in two Sicilian municipalities (N = 14,540, as of November 1, 1987). Material & methods - During phase 1, we administered a brief screening instrument to subjects in the study population. In phase 2, study neurologists using specified diagnostic criteria investigated those subjects who screened positive. Our case finding was restricted to subjects who manifested symptoms of LR in the six months preceding the prevalence day. Results - We found 143 subjects affected by LR (112 definite, 31 possible) yielding a crude prevalence of 9.8 cases per 1,000 population…

education.field_of_studymedicine.medical_specialtyPediatricsNeuroscience (all)Epidemiologybusiness.industryPopulationLumbosacral radiculopathyGeneral MedicineNeurologyEpidemiologyPrevalencemedicinePhysical therapyCase findingPopulation studySettore MED/26 - NeurologiaNeurology (clinical)Lumbosacral radiculopathyNeurologic diseaseeducationbusinessScreening instrumentLumbosacral joint
researchProduct

Oligodendroglioma cells synthesize the differentiation-specific linker histone H1˚ and release it into the extracellular environment through shed ves…

2013

Chromatin remodelling can be involved in some of the epigenetic modifications found in tumor cells. One of the mechanisms at the basis of chromatin dynamics is likely to be synthesis and incorporation of replacement histone variants, such as the H1° linker histone. Regulation of the expression of this protein can thus be critical in tumorigenesis. In developing brain, H1° expression is mainly regulated at the post-transcriptional level and RNA-binding proteins (RBPs) are involved. In the past, attention mainly focused on the whole brain or isolated neurons and little information is available on H1° expression in other brain cells. Even less is known relating to tumor glial cells. In this st…

Cancer ResearchOligodendrogliomaGene Expressionmedicine.disease_causeHistonessheddingHistone H1Settore BIO/10 - BiochimicaGene expressionmedicineAnimalsRNA MessengerEpigeneticsRats WistarSettore BIO/06 - Anatomia Comparata E CitologiaTransport Vesicleshistone variantsCells CulturedCell NucleusMessenger RNAbiologyBrain NeoplasmsastrocytesBrainRNA-Binding ProteinsArticlesH1° histoneCell cycleChromatin Assembly and DisassemblyRatsChromatinCell biologyCell Transformation Neoplasticoligodendroglioma cellsHistoneOncologyoligodendroglioma cells astrocytes post-transcriptional regulation histone variants H1˚ histone RNA-binding proteins extracellular vesicles sheddingbiology.proteinextracellular vesiclesCarcinogenesispost-transcriptional regulation
researchProduct

Risk of Parkinson disease in women: Effect of reproductive characteristics

2004

Objective: To investigate the association between some fertile life characteristics and Parkinson disease (PD) in women. Methods: Women affected by PD and control subjects were matched one to one by age (±2 years). One hundred thirty-one women with idiopathic PD and 131 matched control subjects were interviewed. Controls were randomly selected from the resident list of the same municipality of residence of cases. All subjects had a Mini-Mental State Examination score of ≥24. Cumulative length of pregnancies, age at menarche, age and type of menopause, and estrogen use before and after menopause were investigated in cases and controls through a structured questionnaire. Models of matched pai…

medicine.medical_specialtyOvariectomySurgical MenopauseRisk FactorsSurveys and QuestionnairesmedicineHumansAge of OnsetReproductive HistoryAgedMenarcheUnivariate analysisLife lengthbusiness.industryObstetricsEstrogen Replacement TherapyCase-control studyEstrogensParkinson DiseaseOdds ratioMiddle Agedmedicine.diseaseSurgeryMenopauseParityItalyCase-Control StudiesMenarcheFemaleNeurology (clinical)MenopauseAge of onsetbusiness
researchProduct

Progressive necrotic encephalopathy following tacrolimus therapy for liver transplantation.

2009

Previously described neurologic damage induced by immunosuppressive treatments includes transient or reversible central nervous system involvement. We describe a 57-year-old man who underwent liver transplantation and was started on immunosuppressive therapy with tacrolimus (FK506). Six months later, he started complaining of a progressive motor and sensory impairment of the left side, together with cognitive impairment. Brain MRI showed an enlarging lesion of the white matter with peripheral contrast enhancement. PET study indicated severe hypometabolism in the right hemisphere and spectroscopic MRI showed a peak of choline and relative reduction of other metabolites. Findings of CSF exami…

MalePathologymedicine.medical_specialtyNeurologyMagnetic Resonance Spectroscopymedicine.medical_treatmentEncephalopathyDermatologyBrain damageLiver transplantationTacrolimusWhite PeopleWhite matterLesionNecrosisProgressive necrotic encephalopathy liver transplantation.MedicineHumansHepatitis ChronicBrain Diseasesbusiness.industrySettore MED/27 - NeurochirurgiaBrainGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance ImagingTacrolimusLiver TransplantationPsychiatry and Mental healthmedicine.anatomical_structurePositron-Emission TomographyDisease ProgressionSettore MED/26 - NeurologiaNeurology (clinical)Neurosurgerymedicine.symptombusinessImmunosuppressive AgentsFollow-Up StudiesNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases

2004

Following an outbreak of bovine spongiform encephalopathy (BSE) in dairy cows in the United Kingdom (UK), 153 definite and probable human cases of new variant Creutzfeldt-Jakob disease (nvCJD) have been reported, almost exclusively in the UK. Although exposure to the BSE agent is the most plausible interpretation for the occurrence of nvCJD, the causal link between the BSE prion and nvCJD is still debated. This review discusses the pros and cons of nvCJD as a separate nosographic entity, the scientific basis for a correlation between BSE and nvCJD, the validity of the current diagnostic criteria for CJD and nvCJD, the contribution of epidemiology to the detection of a causal relation betwee…

Pediatricsmedicine.medical_specialtyMeatEncephalopathy Bovine Spongiform Encephalopathy Bovine SpongiformBovine spongiform encephalopathyEncephalopathyDermatologyDiseaseCreutzfeldt-Jakob SyndromeAnimalsHumansMedicinebovine spongiform encephalopathybusiness.industryCausal relationsGeneral MedicineNew variantmedicine.diseaseVirologyCreutzfeldt-Jakob diseaseEncephalopathy Bovine SpongiformPsychiatry and Mental healthCattleCausal linkepidemiologyNeurology (clinical)business
researchProduct

In patient’s with Parkinson disease, autonomic symptoms are frequent and associated with other non-motor symptoms

2015

Background: Autonomic symptoms and sleep disorders are common non-motor symptoms of Parkinson disease (PD), which are correlated with poor quality of life for patients. Purpose: To assess the frequency of autonomic symptoms in a consecutive series of PD patients and to correlate them with other motor and non-motor symptoms. Methods: All consecutive non-demented PD patients who underwent an extensive evaluation including Hoehn and Yahr staging, Unified Parkinson’s Disease Rating Scale, Beck’s Depression Inventory, Neuropsychiatric Inventory, PDQ-39 Scale, the Parkinson’s diseases Sleep Scale, the Epworth Sleepiness Scale and SCOPA-AUT scale were enrolled. Comorbidity has been also considered…

Malemedicine.medical_specialtyLevodopaNeurologyParkinson's diseaseDiseaseAutonomic symptomNon-motor symptomRating scaleInternal medicinemedicineHumansDepression (differential diagnoses)AgedEndocrine and Autonomic Systemsbusiness.industryEpworth Sleepiness ScaleParkinson DiseaseSleep disordersMiddle Agedmedicine.diseaseComorbidityCross-Sectional StudiesAutonomic Nervous System DiseasesParkinson’s diseaseFemaleSettore MED/26 - NeurologiaNeurology (clinical)businessmedicine.drug
researchProduct

Attrition and Use of Proxy Respondents and Auxiliary Information in the Sicilian Neuroepidemiologic Study

1994

Two-phase prevalence surveys with screening (phase 1) and examination (phase 2) are useful for some chronic diseases. Attrition, which may bias estimates, occurs in either phase because some eligible subjects die before contact, some refuse to cooperate, some are incapacitated, and some are unreachable. This investigation relates to a survey of neurologic diseases conducted in three municipalities of Sicily (prevalence date, November 1, 1987) and considers the attrition experienced and the use of proxy respondents in phase 1 and auxiliary information in phase 2 to offset, in part, this attrition. Regarding case finding, the salvage effort was more productive for decreased and incapacitated …

AdultMaleProxy respondentsmedicine.medical_specialtyAdolescentEpidemiologybusiness.industryData CollectionPublic healthMiddle Agedmedicine.diseaseProxy (climate)Impaired consciousnessChronic diseaseItalyEpidemiologymedicineHumansCase findingFemaleAttritionNervous System DiseasesEpidemiologic MethodsbusinessDemographyAmerican Journal of Epidemiology
researchProduct

Natalizumab: a country-based surveillance program

2008

Natalizumab is a humanized monoclonal antibody with a selective adhesion-molecule inhibitor effect, and a demonstrated efficacy in decreasing the frequency of relapses and progression of disability in relapsing-remitting multiple sclerosis (RR MS). After the approval of FDA and EMEA in MS cases unresponsive to immunomodulating therapy or in severe MS patients also not previously treated with interferons, and considering the concern on the possible side effects, an accurate program of surveillance was organized in our country by a combined effort of AIFA, Cineca, Department of Pharmacology of University of Bologna, and a group of neurologists appointed by the National Society of Neurology (S…

AdultMalemedicine.medical_specialtyNeurologyDatabases FactualDrug-Related Side Effects and Adverse ReactionsNational Health ProgramsDrug ResistanceDermatologyDiseaseAntibodies Monoclonal HumanizedNatalizumabInternal medicineOutcome Assessment Health CareMultiple SclerosiPharmacovigilanceProduct Surveillance PostmarketingmedicineAdverse Drug Reaction Reporting SystemsHumansImmunologic FactorsMULTIPLE SCLEROSISNATALIZUMABClinical Trials as Topicbusiness.industryMultiple sclerosisAntibodies MonoclonalMean ageGeneral Medicinemedicine.diseasePsychiatry and Mental healthItalyREGISTRYPHARMACOVIGILANCEPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)NeurosurgerybusinessPreviously treatedFollow-Up Studiesmedicine.drug
researchProduct

Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients

2009

Abstract Multiple Sclerosis (MS) patients present a decrease of antioxidants and neuroprotective and immunoregulatory vitamins and an increase of total homocysteine (tHcy), cholesterol (CHL), HDL-cholesterol, and of cellular stress markers, variably associated with the different phases of the disease. We compared the blood levels of uric acid, folic acid, vitamins B12, A, and E, tHcy, CHL, HDL-cholesterol, and triglycerides in forty MS patients during a phase of clinical inactivity with those of eighty healthy controls, matched for age and sex. We found higher levels of tHcy (p = 0.032) and of HDL-cholesterol (p = 0.001) and lower levels of vitamin E (p = 0.001) and the ratio vitamin E/CHL …

AdultMalemedicine.medical_specialtyMultiple SclerosisAdolescentHomocysteineEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryBlood lipidsClinical nutritionBiologyAntioxidantschemistry.chemical_compoundFolic AcidEndocrinologyHigh-density lipoproteinSettore BIO/10 - BiochimicaInternal medicinemedicineHumansShort PaperVitamin B12Homocysteinelcsh:RC620-627TriglyceridesBiochemistry medicalCholesterolVitamin EBiochemistry (medical)VitaminsMiddle AgedLipidsUric Acidlcsh:Nutritional diseases. Deficiency diseasesEndocrinologychemistryCase-Control StudiesUric acidSettore MED/26 - NeurologiaFemalelipids (amino acids peptides and proteins)Lipids in Health and Disease
researchProduct

Reversible Pisa Syndrome in a patient with Parkinson's disease on rasagiline therapy

2013

RasagilinePediatricsmedicine.medical_specialtyParkinson's diseasebusiness.industrymedicine.diseasechemistry.chemical_compoundNeurologychemistryPhysical therapyMedicineNeurology (clinical)businessPisa Syndrome rasagilineJournal of the Neurological Sciences
researchProduct

CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers

2003

We re-evaluated the association with multiple sclerosis (MS) of the C77G splicing regulatory variation in the CD45 gene and screened for new mutations the three alternatively spliced exons (#4, 5 and 6). No association with C77G was detected in two groups of patients (total=448) and controls (total=559) from Northern and Southern Italy. When excluding the first published study indicating a positive association, a meta-analysis of the five further studies conducted to date (including the present one) led to a non-significant combined odds ratio (OR) of 1.11. None of the four newly identified nucleotide substitutions, namely C77T (Pro59Pro) in exon 4, G69C (Asp121His) in exon 5, T127A (Ile187…

Genetic MarkersMaleGuanineMultiple SclerosisGenotypeImmunologyBiologyCytosineExonGene FrequencymedicineHumansImmunology and AllergyGeneAllelesGeneticsPolymorphism GeneticMultiple sclerosisGenetic VariationExonsOdds ratiomedicine.diseaseMolecular biologyAlternative SplicingNeurologyMeta-analysisRNA splicingLeukocyte Common AntigensFemaleNeurology (clinical)Journal of Neuroimmunology
researchProduct

Accuracy of death certificates for motor neuron disease and multiple sclerosis in the province of Palermo in southern Italy

2002

Mortality studies based on death certificates (DCs) are relatively inexpensive and easy to conduct. Therefore, they are frequently used to evaluate variations of geographical and temporal patterns, particularly in uncommon diseases. Recent surveys of motor neuron disease (MND) and multiple sclerosis (MS) based on official mortality statistics in Italy showed a decreasing trend of mortality from northern to southern Italy. To evaluate if DCs are homogeneously recorded in Italy and whether or not they can be considered a good instrument for mortality studies, we assessed the accuracy of DCs for MND and MS in the province of Palermo, Italy, and compared our results with those reported in other…

MalePediatricsmedicine.medical_specialtyMultiple SclerosisEpidemiologyUnderlying cause of deathDiseaseDeath CertificatesmedicineHumansMultiple sclerosiMotor neuron diseaseArchivesbusiness.industryMultiple sclerosisMortality rateMortality statisticsMiddle AgedMotor neuronmedicine.diseaseMortality rateConfidence intervalDeath certificatemedicine.anatomical_structureItalyFemaleSettore MED/26 - NeurologiaNeurology (clinical)business
researchProduct

Refsum disease. Clinical and morphological report on a case

1982

An atypical case of Refsum disease is reported together with the peripheral nerve morphological data. The body fluids must be assayed for phytanic acid whenever an atypical chronic peripheral neuropathy is observed.

Malemedicine.medical_specialtyPathologyNeurologyAdolescentPhytanic acidDermatologychemistry.chemical_compoundPeripheral nerveHumansMedicineNeuroradiologybusiness.industryGeneral NeuroscienceGeneral Medicinemedicine.diseaseChronic PolyneuropathyBody FluidsPhytanic AcidPsychiatry and Mental healthRefsum diseasePeripheral neuropathychemistryRefsum DiseaseNeurology (clinical)NeurosurgerybusinessThe Italian Journal of Neurological Sciences
researchProduct

Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.

2021

Summary Background Among asymptomatic patients with severe carotid artery stenosis but no recent stroke or transient cerebral ischaemia, either carotid artery stenting (CAS) or carotid endarterectomy (CEA) can restore patency and reduce long-term stroke risks. However, from recent national registry data, each option causes about 1% procedural risk of disabling stroke or death. Comparison of their long-term protective effects requires large-scale randomised evidence. Methods ACST-2 is an international multicentre randomised trial of CAS versus CEA among asymptomatic patients with severe stenosis thought to require intervention, interpreted with all other relevant trials. Patients were eligib…

Malemedicine.medical_specialtyTime FactorsTime Factormedicine.medical_treatmentCarotid StenosiMEDLINECarotid endarterectomyRate ratioRisk AssessmentAsymptomaticlaw.inventionRandomized controlled triallawRisk Factorscarotid artery stenting (CAS); carotid endarterectomy (CEA)StentmedicineHumansCarotid StenosisStrokeEndarterectomyAgedEndarterectomy Carotidbusiness.industrycarotid arteryRisk FactorArticlesGeneral Medicinetrialmedicine.diseaseSettore MED/22 - CHIRURGIA VASCOLARESurgeryStrokeStenosisTreatment Outcomecarotid artery stenting (CAS)Settore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREFemaleStentsHuman medicinemedicine.symptomcarotid endarterectomy (CEA)businessHumanLancet (London, England)
researchProduct

How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire.

2008

We used a CAPSIT-based questionnaire to estimate the percentage of parkinsonian patients suitable for subthalamic nucleus (STN) deep brain stimulation (DBS) in a movement disorders clinic. We found that out of 641 consecutive PD patients only 1.6% fulfilled strict STN-DBS criteria. When we applied more flexible criteria, the percentage of eligibility increased to 4.5%. Most patients (60%) were ineligible because they did not satisfy multiple questionnaire items. Items related to disease severity were responsible for the largest number of exclusions. This knowledge will help make decisions on resource allocation in centres wishing to start DBS surgery.

AdultMalemedicine.medical_specialtyParkinson's diseaseMovement disordersNeurologyDeep brain stimulationDeep Brain Stimulationmedicine.medical_treatmentParkinson Desease Deep Brain StimulationAudiologybehavioral disciplines and activitiesDisease severityParkinsonian DisordersSubthalamic NucleusSurveys and QuestionnairesmedicineHumansAgedChi-Square Distributionbusiness.industryPatient SelectionMiddle Agedmedicine.diseasenervous system diseasesSubthalamic nucleussurgical procedures operativenervous systemNeurologyCAPSIT; Parkinson's disease; Questionnaire; STN DBS; Adult; Aged; Chi-Square Distribution; Deep Brain Stimulation; Female; Humans; Male; Middle Aged; Parkinsonian Disorders; Subthalamic Nucleus; Surveys and Questionnaires; Patient Selection; Aging; Neurology (clinical); NeurologyPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)medicine.symptomGeriatrics and GerontologyPsychologybusinesstherapeuticsNeuroscienceNeurology; Geriatrics and Gerontology; Neurology (clinical)
researchProduct

A screening instrument for a Sicilian neuroepidemiological survey in the elderly.

2003

Abstract We evaluated the sensitivity and specificity of a screening instrument developed for use in a two-phase neuroepidemiological survey in Sicily. The Sicilian Epidemiological Dementia Study (SEDES) project will evaluate the prevalence and incidence of dementia, parkinsonisms and essential tremor in four Sicilian municipalities. It is a two-phase door-to-door survey. To identify subjects with possible neurological disorders, in this study, we developed a screening instrument including a symptoms questionnaire and simple physical tasks for parkinsonisms and essential tremor. The Mini-Mental State Examination (MMSE) was chosen for screening dementia. The symptoms questionnaire and simple…

MaleAgingmedicine.medical_specialtyHealth (social science)NeurologyParkinsonismSensitivity and SpecificityElderlySurveys and QuestionnairesValidationEpidemiologyTremormedicinePrevalenceDementiaHumansScreening instrumentGeriatric AssessmentSicilyAgedAged 80 and overEssential tremorbusiness.industryParkinsonismIncidence (epidemiology)IncidenceHealthy subjectsParkinson Diseasemedicine.diseasenervous system diseasesScreening instrumentPhysical therapyEssential tremorDementiaFemaleGeriatrics and GerontologybusinessEpidemiologic MethodsGerontologyArchives of gerontology and geriatrics
researchProduct

Multiple sclerosis severity score: Using disability and disease duration to rate disease severity

2005

Background: There is no consensus method for determining progression of disability in patients with multiple sclerosis (MS) when each patient has had only a single assessment in the course of the disease. Methods: Using data from two large longitudinal databases, the authors tested whether cross-sectional disability assessments are representative of disease severity as a whole. An algorithm, the Multiple Sclerosis Severity Score (MSSS), which relates scores on the Expanded Disability Status Scale (EDSS) to the distribution of disability in patients with comparable disease durations, was devised and then applied to a collection of 9,892 patients from 11 countries to create the Global MSSS. I…

AdultMalemedicine.medical_specialtyMultiple SclerosisDatabases FactualCross-sectional studyModels NeurologicalDiseaseSUSCEPTIBILITYSeverity of Illness IndexCohort StudiesDisability EvaluationPredictive Value of TestsRecurrenceSeverity of illnessmedicineHumansLongitudinal StudiesAge of OnsetModels StatisticalExpanded Disability Status Scalebusiness.industryMultiple sclerosisOUTCOME MEASUREReproducibility of ResultsNATURAL-HISTORYMiddle AgedPrognosismedicine.diseaseCross-Sectional StudiesPredictive value of testsDisease ProgressionPhysical therapyFemaleFranceNeurology (clinical)Age of onsetbusinessCohort study
researchProduct

Height as an indicator of eraly life events predicting Parkinson's disease: A case-control study

2006

researchProduct

Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study

2017

Abstract Background The association between multiple sclerosis (MS) and cancer has long been investigated with conflicting results. Several reports suggest an increased cancer risk among MS patients treated with immunosuppressant (IS) drugs. Methods We performed a cohort study including MS patients recruited at the Neurological Department of the University of Palermo. Mean follow-up period was ten years for the whole cohort. We calculated cancer incidence among patients treated with IS. Incidence rates were compared in the cohort by calculating the relative risk according to length and dose of exposure to IS. Cancer incidence among MS patients was compared to cancer incidence in the general…

AdultMaleRiskmedicine.medical_specialtyMultiple SclerosisPopulationlcsh:RC346-429Cohort StudiesYoung Adult03 medical and health sciences0302 clinical medicineNeoplasmsInternal medicinemedicineHumansMultiple sclerosiCancer; Cohort study; Immunosuppressant; Multiple sclerosis; Treatment; Neurology (clinical)Prospective cohort studyeducationlcsh:Neurology. Diseases of the nervous systemCancerImmunosuppressanteducation.field_of_studybusiness.industryIncidenceMultiple sclerosisCancerRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseSurgeryTreatment030220 oncology & carcinogenesisRelative riskCohortFemaleNeurology (clinical)Cohort studybusinessImmunosuppressive Agents030217 neurology & neurosurgeryResearch ArticleCohort studyBMC Neurology
researchProduct

Prevalence of diabetic neuropathy with somatic symptoms

1993

In a door-to-door survey conducted in two municipalities of Sicily, we ascertained the prevalence of diabetic neuropathy. Our case-finding was restricted to subjects with somatic symptoms. During phase 1, we administered a screening instrument for peripheral neuropathy to 14,540 persons residing in Santa Teresa di Riva (Messina Province) and Terrasini (Palermo Province). During phase 2, neurologists evaluated those subjects who had screened positive. Diagnoses were based on clinical criteria only, and were reviewed by an adjudication panel. We found 39 persons (27 women, 12 men) affected by diabetic neuropathy. The crude prevalence, as of November 1, 1987, was 268.2 cases per 100,000 popula…

medicine.medical_specialtyeducation.field_of_studyPediatricsDiabetic neuropathybusiness.industryPopulationmedicine.diseaseSurgeryPeripheral neuropathyDiabetes mellitusEpidemiologymedicineNeurology (clinical)businesseducationComplicationMass screeningSex characteristicsNeurology
researchProduct

Prevalence and risk factors of post-polio syndrome in a cohort of polio survivors.

2005

Abstract Objective To investigate frequency and associated factors of post polio syndrome (PPS) in an Italian cohort of people with prior poliomyelitis. Methods We screened subjects admitted for poliomyelitis at the paediatric hospital of the University of Palermo during the time frame 1945–1960. Patients who developed PPS were identified through a structured questionnaire and a neurologic examination. PPS diagnosis was made according to specified diagnostic criteria. Frequency of PPS was calculated in the selected cohort of polio survivors. The association with the investigated risk factors (sex, age at onset of polio, extension and severity of polio, education, associated diseases, cigare…

Malemedicine.medical_specialtyPediatricseducationPrevalenceCohort StudiesPost-polio syndromeRisk FactorsSurveys and QuestionnairesmedicinePrevalenceHumansRisk factorhealth care economics and organizationsNeurologic ExaminationChi-Square Distributionbusiness.industryOdds ratioMiddle Agedmedicine.diseasePolio VaccinationPoliomyelitisSurgeryPoliomyelitiNeurologyCohortPost-polio syndromeSettore MED/26 - NeurologiaFemaleRisk factorNeurology (clinical)Postpoliomyelitis SyndromeCohort studybusinessCohort studyPoliomyelitisJournal of the neurological sciences
researchProduct

Mortality in multiple sclerosis: a review

2008

This work was undertaken to evaluate studies on mortality caused by multiple sclerosis (MS), to evaluate if useful inferences can be drawn from survival studies that can be applied to clinical practice. A literature search was carried out to find epidemiological studies on MS prognosis, survival, mortality and causes of death relevant to our aim. The World Health Organization (WHO) reports on worldwide cause-specific mortality were also considered. Studies were evaluated according to the duration of the follow-up study, the year of publication and the methodology used. We evaluated MS survival from a methodological point of view and considered if time trends could be drawn from study result…

medicine.medical_specialtyeducation.field_of_studyPediatricsbusiness.industryMultiple sclerosisDisease durationPopulationmedicine.diseaseWorld healthClinical PracticeNeurologyOlder patientsEpidemiologymedicineNeurology (clinical)businessIntensive care medicineeducationCause of deathEuropean Journal of Neurology
researchProduct

Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease

2015

Dear Editor, We have read with interest comments by Solla et al. [1] regarding our Letter to the Editor published in NeurologicalSciences titled ‘‘Insidious onset of Pisa Syndrome afterrasagiline therapy in a patient with Parkinson’s Disease’’[2]. We thank the authors for their interest in our paper, but we think it is necessary to make some clarifications regarding the temporal relationship between the onset of Pisa Syndrome (PS) and rasagiline therapy. PS occurred in fact after and not before rasagiline treatment as stated by Solla et al. In particular, PS occurred after a time interval of 6–12 months and anyway after rasagiline was added to patient’s therapy. This long time interval is o…

Pediatricsmedicine.medical_specialtyParkinson's diseaseNeurologyParkinson's diseaseDermatologyAntiparkinson Agentschemistry.chemical_compoundDopaminemedicineHumansMonoamine Oxidase Type BDystoniaRasagilineAntiparkinsonian drugsbusiness.industryParkinson DiseaseGeneral Medicinemedicine.diseasePsychiatry and Mental healthDystoniaPisa syndromechemistryAntiparkinson AgentsIndansFemaleNeurology (clinical)businessmedicine.drug
researchProduct

Multiple sclerosis: Haemorheological pattern

2016

medicine.medical_specialtyPhysiologybusiness.industryPhysiology (medical)Multiple sclerosisImmunologyMedicineHematologyCardiology and Cardiovascular Medicinebusinessmedicine.diseaseDermatologyClinical Hemorheology and Microcirculation
researchProduct

Long-term survival and outcome after first stroke in the Sicilian Aeolian Island Archipelago population.

2007

Background: Only a restricted number of population studies based on long-term prognosis after a stroke have been published. We analyzed long-term survival and outcome in insular first-ever stroke population from the Aeolian Archipelago. Subjects and methods: From 1 July, 1999 to 30 June 2002, 62 patients with first-ever stroke were recruited to evaluate short-term incidence and outcome. Information for every patient was collected by phone interviews after 3 months, 1 year, and 4 years. Results: 30 days case fatality rate was 24.2% (95% C.I. 14.22 to 36.75). Fifty-one percent (95% C.I. 35.8 to 66.3) of patients died before last survey and 39.1% died during the first year of follow-up. Annual…

Malemedicine.medical_specialtyNeurologyPopulationDermatologysurvivalHealth Services AccessibilityCohort StudiesInterviews as TopicMediterranean IslandsMedicineHumanscardiovascular diseasesSurvivorseducationStrokeSicilyNeuroradiologyAgedAged 80 and overgeographyeducation.field_of_studygeography.geographical_feature_categorybusiness.industryIncidenceGeneral MedicineMiddle Agedmedicine.diseaselanguage.human_languageStrokeSurvival RatePsychiatry and Mental healthCerebrovascular DisordersArchipelagolanguageAeolian processesSettore MED/26 - NeurologiaFemaleNeurology (clinical)NeurosurgerybusinessSicilianDemographyFollow-Up StudiesNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Neuronal and BBB damage induced by sera from patients with secondary progressive multiple sclerosis.

2009

An important component of the pathogenic process of multiple sclerosis (MS) is the blood-brain barrier (BBB) damage. We recently set an in vitro model of BBB, based on a three-cell-type co-culture system, in which rat neurons and astrocytes synergistically induce brain capillary endothelial cells to form a monolayer with permeability properties resembling those of the physiological BBB. Herein we report that the serum from patients with secondary progressive multiple sclerosis (SPMS) has a damaging effect on isolated neurons. This finding suggests that neuronal damaging in MS could be a primary event and not only secondary to myelin damage, as generally assumed. SPMS serum affects the perme…

Pathologymedicine.medical_specialtyProgrammed cell deathBlotting WesternBiologyImmunofluorescenceOccludinModels BiologicalMyelinWestern blotOccludinGeneticsmedicineElectric ImpedanceAnimalsmultiple sclerosis brain cell cultures in vitro models of blood-brain barrier neuronal cell death transendothelial electrical resistanceMicroscopy Phase-ContrastRats WistarCells CulturedNeuronsmedicine.diagnostic_testTight junctionCell DeathMultiple sclerosisMembrane ProteinsGeneral MedicineMultiple Sclerosis Chronic Progressivemedicine.diseaseImmunohistochemistryRatsBlotmedicine.anatomical_structurenervous systemBlood-Brain BarrierAstrocytescardiovascular systemInternational journal of molecular medicine
researchProduct

Lack of association between ubiquitin carboxy-terminal hydrolase L1 gene polymorphism and PD.

2001

In 1998, an IL93Met mutation in the ubiquitin carboxy-terminal hydrolase L1 ( UCH-L1 ) gene was identified in a German family affected by PD.1 Recently, others2-4⇓⇓ found that the S18Y polymorphism in exon 3 of UCH-L1 is associated with a low risk of PD. To verify these interesting results, we decided to design a case-control study on the S18Y polymorphism of the UCH-L1 gene using sporadic PD cases. In the meantime, as we were analyzing our samples, a case-control study5 on 142 patients with PD and 142 age- and sex-matched control subjects did not confirm the protective effect found by Maraganore et al.2 In view of these conflicting findings, we reasoned that our contribution may have some …

AdultMaleallele frequenciesParkinson's diseasegenotypepolymorphismlaw.inventionExonDegenerative diseaseUbiquitinlawHydrolasemedicineHumansGeneNeural Cell Adhesion MoleculesPolymerase chain reactionAgedAged 80 and overNeuroscience (all)Membrane GlycoproteinsPolymorphism GeneticbiologyUCH-L1 geneParkinson DiseaseMiddle Agedmedicine.diseaseUbiquitin carboxy-terminal hydrolase L1Settore BIO/18 - GeneticaImmunologybiology.proteinSettore MED/26 - NeurologiaFemaleNeurology (clinical)Gene polymorphismThiolester HydrolasesLeukocyte L1 Antigen ComplexUbiquitin ThiolesteraseNeurology
researchProduct

Identification of the novel D297fsX318 PINK1 mutation and phenotype variation in a family with early-onset Parkinson's disease

2008

Herein we first describe a novel homozygous single nucleotide deletion in PINK1 exon 4 (889delG) which results in a loss of kinase domain on the PINK1 protein (D297fsX318). This mutation was identified in two brothers with early-onset Parkinson disease (EOPD) from a Sicilian consanguineous family. Of note, while one of the two patients developed mental deterioration and psychiatric problems, the other showed no cognitive decline. The present study supports the view that PINK1 is a pathogenic gene in some Italian families with EOPD and contributes to define the PINK1-associated phenotype. Herein we first describe a novel homozygous single nucleotide deletion in PINK1 exon 4 (889delG) which r…

MaleParkinson's diseaseGenotypeParkinson's diseaseMolecular Sequence DataPINK1DiseaseBiologyAntiparkinson AgentsLevodopaExonmedicineHumansAmino Acid SequenceAge of OnsetCognitive declineGeneAgedGeneticsGenotype–phenotype correlationPINK1Parkinson DiseaseExonsFamilial formmedicine.diseasePhenotypePedigreeSettore BIO/18 - GeneticaPhenotypeNeurologyMutationMutation (genetic algorithm)Settore MED/26 - NeurologiaNeurology (clinical)Geriatrics and GerontologyCognition DisordersProtein KinasesGene DeletionParkinsonism & Related Disorders
researchProduct

Diabetes preceding Parkinson's disease onset. A case–control study

2009

Abstract Objective To assess the association between diabetes preceding Parkinson's disease (PD) and PD. Methods PD individuals were matched to PD free individuals randomly selected from people in the same municipality as the cases. Occurrence of diabetes preceding PD onset among cases and controls was assessed through a structured questionnaire. Information regarding current and past medical treatment and other variables was also collected. We used univariate and multivariate logistic models to calculate crude and adjusted odds ratios (OR). Covariates are adjusted for included education, smoking habit, alcohol and coffee consumption. Results 318 PD individuals (165 women, 153 men) and 318 …

Malemedicine.medical_specialtyParkinson's diseaseMultivariate analysiscase-control studyComorbidityDiseaseDiabeteRisk FactorsDiabetes mellitusInternal medicineEpidemiologyDiabetes MellitusmedicineHumansParkinson's Diseasebusiness.industryCase-control studyParkinson DiseaseOdds ratioMiddle Agedmedicine.diseaseNeurologyCase-Control StudiesSettore MED/26 - NeurologiaFemaleNeurology (clinical)Geriatrics and GerontologybusinessBody mass indexParkinsonism & Related Disorders
researchProduct

Tumor Diagnosis Preceding Alzheimer's Disease Onset: Is There a Link Between Cancer and Alzheimer's Disease?

2012

Studies reporting an inverse association between Alzheimer's disease (AD) and cancer are scant. Available data are mostly based on ancillary findings of mortality data or obtained from studies evaluating frequency of neoplasms in AD patients independently if they occurred before or after AD. Moreover, some studies estimated frequencies of neoplasms in demented individuals, who were not necessarily AD patients. We estimated frequency of tumors preceding the onset of AD in AD patients and compared it to that of age- and gender-matched AD-free individuals. Occurrence of tumors preceding AD onset was assessed through a semi-structured questionnaire. Tumors were categorized as benign, malignant,…

MaleAlzheimer's disease cancer epidemiologyOncologymedicine.medical_specialtyDiseaseAssociationSex FactorsAlzheimer DiseaseRisk FactorsInternal medicineEpidemiologyOdds RatiomedicineHumansAge of OnsetAgedRetrospective StudiesAged 80 and overBrain Neoplasmsbusiness.industryGeneral NeuroscienceCase-control studyCancerRetrospective cohort studyGeneral MedicineOdds ratiomedicine.diseasePsychiatry and Mental healthClinical PsychologyCase-Control StudiesDisease ProgressionFemaleSettore MED/26 - NeurologiaGeriatrics and GerontologyAlzheimer's diseaseAge of onsetbusinessJournal of Alzheimer's Disease
researchProduct

Reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura

2011

Thrombotic thrombocytopenic purpura (TTP) is an autoimmune disorder characterised by fever, microangiopathic haemolytic anaemia, renal insufficiency, and thrombocytopenia. Neurological involvement, a prominent component of TTP, is characterised by a variety of brain lesions which include reversible cerebral oedema or magnetic resonance imaging (MRI) features of reversible posterior leukoencephalopathy syndrome (RPLS). TTP is frequently associated with deficiency of the von Willebrand factor-cleaving protease, ADAMTS13.Here, we report a case of TTP with severe acute encephalopathy. Posterior leukoencephalopathy and brainstem oedema with triventricular hydrocephalus were observed on MRI. The …

Malemedicine.medical_specialtyPathologyNeurologyThrombotic thrombocytopenic purpuraAnti-Inflammatory AgentsDermatologyMethylprednisolonehemic and lymphatic diseasesmedicineHumansmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingGeneral MedicinePlasmapheresisMiddle Agedmedicine.diseaseReversible posterior leukoencephalopathy Thrombotic thrombocytopenic purpura ADAMTS-13Plasma exchangeADAMTS13SchistocyteSurgeryHydrocephalusPsychiatry and Mental healthPurpuraTreatment OutcomeMethylprednisolonePurpura ThrombocytopenicSettore MED/26 - NeurologiaNeurology (clinical)Posterior Leukoencephalopathy Syndromemedicine.symptombusinessmedicine.drug
researchProduct

Prevalence of red ear syndrome in juvenile primary headaches.

2010

Background: Previous studies have suggested a relationship between ‘red ear syndrome’ (RES) and pediatric migraine. Aims of this study were (i) to assess the frequency, specificity and sensitivity of RES in a population of pediatric migraineurs and (ii) to establish the pathophysiological mechanisms of RES associated with migraine. Methods and results: A total of 226 children suffering from headache (aged 4–17 years) were enrolled. One hundred and seventy-two (76.4%) were affected by migraine, the remaining 54 (23.6%) by other primary headaches. RES was followed significantly more frequently by migraine (23.3%; p < .0001), and was characterized by high specificity and positive predictiv…

Pediatric migraineMalemedicine.medical_specialtyAdolescentRed ear syndromebusiness.industryMigraine DisordersGeneral Medicinemedicine.diseaseDermatologyPrimary headacheAnesthesiaChild PreschoolmedicinePrevalenceJuvenileRed ear syndrome pediatric migraine trigeminal autonomic cephalgias parasympathetic system trigeminal-autonomic reflexHumansSettore MED/26 - NeurologiaFemaleNeurology (clinical)Trigeminal autonomic reflexbusinessChildEar DiseasesCephalalgia : an international journal of headache
researchProduct

Age at menopause predicts age at onset of Parkinson's disease.

2006

We investigated the association between age at onset of Parkinson's disease (PD) and fertile life characteristics in 145 women. Linear regression analyses showed a significant correlation between age at PD onset and age at menopause (P = 0.003), between age at PD onset and fertile life duration (P = 0.008), and a nonsignificant correlation between PD onset and cumulative duration of pregnancies (P = 0.23). These results support the possible role of estrogens in PD.

AdultAgingmedicine.medical_specialtyParkinson's diseasePhysiologyDiseaseRisk AssessmentCentral nervous system diseaseDegenerative diseasefertile lifePregnancyRisk FactorsInternal medicineage at menopausemedicineHumansAge of OnsetRisk factorAgedAged 80 and overPregnancybusiness.industryParkinson DiseaseMiddle Agedmedicine.diseaseMenopauseEndocrinologyNeurologyParkinson’s diseaseLinear ModelsSettore MED/26 - NeurologiaFemalewomenNeurology (clinical)MenopauseAge of onsetbusiness
researchProduct

Occupation, education, and Parkinson's disease: A case-control study in an Italian population

1996

Current epidemiologic data on the association between occupational exposures and Parkinson's disease (PD) are inconsistent. In a case-control study, we investigated the associations between occupation and PD and between education and PD. The cases (n = 62) were those identified in a prevalence survey (door-to-door, two-phase) of three Sicilian municipalities, as a November 1, 1987. We then randomly selected from the general population two controls for each case, matched for age ( +/- year), sex, and municipality (n = 124). Information on current and past occupations and education for cases and controls was obtained during the survey. Subjects who worked for most of their lives as farmers we…

AdultMalemedicine.medical_specialtyParkinson's diseasePopulationOccupational diseaseDiseaseRisk FactorsOccupational ExposureEpidemiologyHumansMedicineParkinson Disease SecondaryRisk factoreducationAgededucation.field_of_studybusiness.industryCase-control studyAgricultureMiddle Agedmedicine.diseaseItalian populationAgricultural Workers' DiseasesOccupational DiseasesItalyNeurologyCase-Control StudiesEducational StatusFemaleNeurology (clinical)businessDemographyMovement Disorders
researchProduct

Multiple sclerosis survival: a population-based study in Sicily

2009

Background and purpose:  There are few population-based surveys on multiple sclerosis (MS) survival. To investigate MS survival in MS patients recruited during surveys conducted in Sicily. Methods:  Multiple sclerosis patients identified during previous surveys were randomly matched to two referent subjects by residence, year of birth, and gender. Living status was obtained by municipality records (end of follow-up June, 30th 2007) and, for the deceased, date and causes of death were searched. Kaplan-Meier plots were used to calculate differences in mortality between MS patients and referent subjects. MS risks for mortality with 95% confidence intervals (CI) were also calculated. Results:  …

Pediatricsmedicine.medical_specialtyeducation.field_of_studybusiness.industryMultiple sclerosisHazard ratioPopulationDiseasemedicine.diseaseConfidence intervalNatural historyNeurologyEpidemiologymedicineNeurology (clinical)businesseducationCohort studyEuropean Journal of Neurology
researchProduct

ASTROCYTES SHED EXTRACELLULAR VESICLES THAT CONTAIN FIBROBLAST GROWTH FACTOR-2 AND VASCULAR ENDOTHELIAL GROWTH FACTOR.

2007

An important component of the pathogenic process of multiple sclerosis (MS) is the blood-brain barrier (BBB) damage. We recently set an in vitro model of BBB, based on a three-cell-type co-culture system, in which rat neurons and astrocytes synergistically induce brain capillary endothelial cells to form a monolayer with permeability properties resembling those of the physiological BBB. Herein we report that the serum from patients with secondary progressive multiple sclerosis (SPMS) has a damaging effect on isolated neurons. This finding suggests that neuronal damaging in MS could be a primary event and not only secondary to myelin damage, as generally assumed. SPMS serum affects the perme…

Vascular Endothelial Growth Factor ACellFluorescent Antibody TechniqueBiologyFibroblast growth factorCulture Media Serum-Freechemistry.chemical_compoundWestern blotSettore BIO/10 - BiochimicaGlial Fibrillary Acidic ProteinGeneticsmedicineAnimalsSecretionFibroblastCells Culturedmedicine.diagnostic_testVesicleIntegrin beta1Secretory VesiclesGeneral MedicineCell biologyRatsVascular endothelial growth factorastrocytesextracellular vesicle sheddingfibroblastic growth factors-2Protein Transportmedicine.anatomical_structureMembrane proteinchemistryAstrocytesFibroblast Growth Factor 2
researchProduct

Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.

2006

Variation in major histocompatibility complex genes on chromosome 6p21.3, specifically the human leukocyte antigen HLA-DR2 or DRB1*1501-DQB1*0602 extended haplotype, confers risk for multiple sclerosis (MS). Previous studies of DRB1 variation and both MS susceptibility and phenotypic expression have lacked statistical power to detect modest genotypic influences, and have demonstrated conflicting results. Results derived from analyses of 1339 MS families indicate DRB1 variation influences MS susceptibility in a complex manner. DRB1*15 was strongly associated in families (P=7.8x10(-31)), and a dominant DRB1*15 dose effect was confirmed (OR=7.5, 95% CI=4.4-13.0, P<0.0001). A modest dose effect…

Models MolecularMaleSequence Homologyimmune system diseasesModelsRisk FactorsDatabases GeneticAdult Alleles Amino Acid Sequence Databases; Genetic Female Genetic Variation Genotype HLA-DR Antigens; chemistry/genetics HLA-DRB1 Chains Humans Male Middle Aged Models; Molecular Molecular Sequence Data Multiple Sclerosis; Chronic Progressive; genetics/immunology Multiple Sclerosis; genetics/immunology Phenotype Risk Factors Sequence Homology; Amino Acidskin and connective tissue diseasesHLA-DRB1Genetics (clinical)GeneticsGeneral MedicineMultiple Sclerosis Chronic ProgressiveMiddle AgedAmino AcidChronic ProgressivePhenotypeFemalemusculoskeletal diseasesAdultMultiple SclerosisGenotypeMolecular Sequence DataLocus (genetics)Human leukocyte antigenBiologyDatabases. Alleles phenotype heterogeneity human leukocyte antigens age of onset chromosomes genes genotype haplotypesmultiple sclerosis relapsing-remitting genetics disability primary progressive multiple sclerosis hla-drb1 gene illness length severity of illnessGeneticGenetic variationGeneticsmedicineHumansAmino Acid SequenceAlleleMolecular BiologyAllelesSequence Homology Amino AcidMultiple sclerosisHaplotypeGenetic VariationMolecularHLA-DR Antigensmedicine.diseasegenetics/immunologychemistry/geneticsImmunologyAge of onsetHLA-DRB1 Chains
researchProduct

Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosi…

2018

This study was designed based on the hypothesis that changes in both the levels and surface marker expression of extracellular vesicles (EVs) isolated from the cerebrospinal fluid (CSF) may be associated with the clinical form, disease activity, and severity of multiple sclerosis (MS). The analyzes were performed on subjects affected by MS or other neurological disorders. EVs, which were isolated by ultracentrifugation of CSF samples, were characterized by flow cytometry. A panel of fluorescent antibodies was used to identify the EV origin: CD4, CCR3, CCR5, CD19, and CD200, as well as isolectin IB4. The Mann–Whitney U-test and Kruskal–Wallis test were used for statistical analyzes. EVs isol…

lymphocytes0301 basic medicinePathologymedicine.medical_specialtyNaive B cellmultiple sclerosisCD19lcsh:RC321-57103 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineCerebrospinal fluidmedicineMultiple sclerosiSettore BIO/06 - Anatomia Comparata E Citologialcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal ResearchAutoimmune diseaseClinically isolated syndromebiologybusiness.industrysurface markersMultiple sclerosismedicine.disease030104 developmental biologyCerebrospinal fluidbiology.proteinLymphocyteSurface markerAntibodyExtracellular vesicleextracellular vesiclesbusiness030217 neurology & neurosurgeryCD8Neuroscience
researchProduct

Prevalence of stroke: A door-to-door survey in three Sicilian municipalities

1996

As part of a door-to-door survey, we screened for stroke among the inhabitants of three Sicilian municipalities (n = 24,496 as of November 1, 1987). Neurologists then investigated those subjects suspected to have had a stroke. Diagnoses of first-ever strokes were based on specified criteria and were reviewed by an adjudication panel. We found 189 subjects who had experienced at least one completed stroke (180 definite, 9 possible); 15 strokes were hemorrhagic, 71 ischemic, and 103 uncertain. The prevalence (cases/100,000) was 771.6 in the total population and 1,893.6 in those aged 40 years or over. The prevalence increased steeply with age, was higher in men between 60 and 79 years, but was…

medicine.medical_specialtyPediatricsIschemic strokebusiness.industryStroke prevalenceEpidemiologyTotal populationmedicine.diseaselanguage.human_languageEpidemiologyIschemic strokelanguageMedicineStroke epidemiologySettore MED/26 - NeurologiaSicily stroke prevalenceNeurology (clinical)businessHemorrhagic strokeStrokeCompleted strokeSicilian
researchProduct

Dentatorubral-pallidoluysian atrophy: haplotype of Asian origin in 2 Italian families.

2011

Asian originMaleNerve Tissue ProteinsBiologyDentatorubral-pallidoluysian atrophyPolymorphism Single NucleotideGeneticAsian PeoplePolymorphism (computer science)medicineHumansGenetic Association StudiesFamily healthGeneticsFamily HealthDentatorubral-pallidoluysian atrophyHaplotypemedicine.diseaseMyoclonic Epilepsies ProgressiveItalian familiesNeurologyHaplotypesItalySettore MED/26 - NeurologiaFemaleNeurology (clinical)Microsatellite RepeatsMovement disorders : official journal of the Movement Disorder Society
researchProduct

Amyotrophic lateral sclerosis in Palermo, Italy: an epidemiological study

1989

The incidence, prevalence and natural course of ALS were determined in the population of the province of Palermo, Italy. The average annual incidence calculated for the years 1973 through 1984, was 044./100.000 inhabitants. The prevalence rate on prevalence day December 31, 1984, was 1.67/100.000 population. The male/female ratio was 1.38. The mean age at onset was 54.3±11.02. The most common clinical form was the conventional one (61.4%); the bulbar form was more frequent among females than males. The mean duration of the disease was 33.7±35.8 months. The longest duration belongs to the pseudopolyneuritic form. The median survival was 36 months: 16 months for the bulbar, 36 months for the …

AdultPediatricsmedicine.medical_specialtyAdolescentprevalencePopulationPrevalenceDermatologyAnnual incidenceEpidemiologyHumansMedicineAmyotrophic lateral sclerosisChildeducationAgedAged 80 and overNatural courseeducation.field_of_studyNeuroscience (all)business.industryGeneral NeuroscienceIncidence (epidemiology)Amyotrophic Lateral SclerosisInfant NewbornInfantGeneral MedicineMiddle Agedmedicine.diseasePsychiatry and Mental healthItalyChild PreschoolincidenceSettore MED/26 - NeurologiaNeurology (clinical)businessMedian survivalAmyotrophic Lateral SclerosiThe Italian Journal of Neurological Sciences
researchProduct

Neurons and ECM regulate occludin localization in brain endothelial cells

2000

We report that extracellular matrix and neurons modulate the expression of occludin, one of the main components of tight junctions, by rat brain endothelial cells (RBE4.B). Of the three extracellular matrix proteins which we tested (collagen I, collagen IV, and laminin), collagen IV stimulated at the best the expression of occludin mRNA. The corresponding protein, however, was not synthesized. Significant amounts of occludin accumulated only when RBE4.B cells were cultured on collagen IV-coated inserts, in the presence of cortical neurons, plated on laminin-coated companion wells. Finally, occludin segregated at the cell periphery, only when endothelial cells were co- cultured with neurons …

Time FactorsEndothelial cellsCellOccludinTight JunctionsExtracellular matrixRats Sprague-DawleyFetusLamininNeurofilament ProteinsOccludinSettore BIO/10 - BiochimicaGlial Fibrillary Acidic ProteinmedicineAnimalsRNA MessengerCells CulturedBlood-brain barrierNeuronsbiologyTight junctionGeneral NeuroscienceBrainMembrane ProteinsCortical NeuronsExtracellular matrixImmunohistochemistryCell biologyRatsEndothelial stem cellmedicine.anatomical_structureMembrane proteinCell cultureSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoCerebrovascular Circulationbiology.proteinSettore MED/26 - NeurologiaCollagenEndothelium VascularLamininNeuroscience
researchProduct

Are Multiple Domicile Changes a Risk Factor for Multiple Sclerosis?

1991

A retrospective case-control study was conducted to estimate the possible association between risk of multiple sclerosis (MS) and the number of changes in residence before the age 20 years. Forty-one patients and 82 controls were interviewed. Using the Mantel-Haenszel estimate of the odds ratio, no association was found between the number of moves and MS.

medicine.medical_specialtyEpidemiologybusiness.industryMultiple sclerosiseducationCase-control studyOdds ratiomedicine.diseasehumanitiesInternal medicinePhysical therapyMedicineResidenceNeurology (clinical)Risk factorbusinessNeuroepidemiology
researchProduct

Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study

2017

Abstract Background Mitoxantrone (MX) has been used as second line therapy for aggressive multiple sclerosis (MS). Potential cardiotoxic effects of MX limit its use; a cumulative dose of up to 100 mg/m2, has been long considered relatively safe. We calculated the frequency of cardiac side effects in MS patients treated with MX. Methods We performed a cohort study including all MS patients treated with MX at the Neurological Department of the University Hospital of Palermo, Italy. Two hundred-sixty-four MS patients diagnosed according to validated criteria were included and followed-up until the end of September 2010. Patients were treated with MX as a second line therapy if they had no prev…

medicine.medical_specialtyImmunologyHeart failureComorbidity030204 cardiovascular system & hematologylcsh:RC346-429Multiple sclerosis03 medical and health sciences0302 clinical medicineInternal medicinemedicineImmunology and AllergyMyocardial infarctionlcsh:Neurology. Diseases of the nervous systemMitoxantroneEjection fractionmedicine.diagnostic_testCumulative dosebusiness.industryComorbidity Multiple sclerosis Heart failure Mitoxantrone Therapymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareNeurologyHeart failureCohortPhysical therapySettore MED/26 - NeurologiaTherapyNeurology (clinical)MitoxantronebusinessElectrocardiography030217 neurology & neurosurgeryCohort studymedicine.drug
researchProduct

Three years of experience : the Italian registry and safety data update

2011

At the end of 2006, a pharmacovigilance program on natalizumab was settled by the Italian Pharmaceutical Agency, and on January 2007, multiple sclerosis patients poorly responding to the immunomodulating therapies or with an aggressive clinical form of disease from onset initiated to be registered and to receive the medication. On February 2010, almost 3,000 cases have been treated with natalizumab. The drop-out rate is 10%. Almost 800 cases received cycles of natalizumab for more than 18 months. One case of PML was reported and other adverse events are similar to those described in phase III studies. The majority of cases remained stable, while in 25% of cases, an improvement of disability…

AdultMalemedicine.medical_specialtyPediatricsMultiple SclerosisDermatologyDiseaseAntibodies Monoclonal HumanizedNatalizumabPharmacovigilanceProduct Surveillance PostmarketingmedicineHumansRegistriesAdverse effectbusiness.industryNatalizumabMultiple sclerosisGeneral Medicinemedicine.diseasePsychiatry and Mental healthItalyPHARMACOVIGILANCEREGISTRYsurveillance program; pharmacovigilance; multiple sclerosis; natalizumabPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)NeurosurgerybusinessMultiple sclerosis NatalizumabSurveillance program Pharmacovigilancemedicine.drug
researchProduct

Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach

2014

Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous system. At present, the molecular mechanisms causing the initiation, development and progression of MS are poorly understood, and no reliable proteinaceous disease markers are available. In this study, we used an immunoproteomics approach to identify autoreactive antibodies in the cerebrospinal fluid of MS patients to use as candidate markers with potential diagnostic value. We identified an autoreactive anti-transferrin antibody that may have a potential link with the development and progression of MS. We found this antibody at high levels also in the serum of MS patients and created an immun…

AdultMaleProteomicsPathologymedicine.medical_specialtyImmunoproteinsimmunoproteomeCentral nervous systemDiseaseBiologymultiple sclerosisProteomicsArticlecerebrospinal fluidCatalysisImmunoproteomicslcsh:ChemistryInorganic ChemistryCerebrospinal fluidSettore BIO/13 - Biologia ApplicatamedicineHumansPhysical and Theoretical Chemistrylcsh:QH301-705.5Molecular BiologySpectroscopyMultiple sclerosisOrganic ChemistryTransferrinCase-control studyGeneral MedicineMiddle Agedmedicine.diseaseComputer Science Applicationsmedicine.anatomical_structurelcsh:Biology (General)lcsh:QD1-999Case-Control Studiesmultiple sclerosiserum biomarkerImmunologyanti-transferrin autoantibodiesbiology.proteinFemaleSettore MED/26 - Neurologiaanti-transferrin autoantibodieAntibodyBiomarkersInternational Journal of Molecular Sciences
researchProduct

BODY MASS INDEX DOES NOT CHANGE BEFORE PARKINSON'S DISEASE ONSET.

2008

Background and purpose:  Previous studies on the association between Parkinson’s disease (PD) and body mass index (BMI) have reported conflicting results. We investigated the relationship between PD and BMI by a case–control study. Methods:  PD patients were randomly matched to healthy individuals by sex and age. BMI distribution in cases has been compared with BMI of controls and odd ratios (ORs) with 95% CI were calculated. Results:  We included 318 PD patients and 318 controls. We observed no association between PD and BMI. BMI distribution in cases and controls was similar also when we adjusted for diabetes, hypercholesterolemia and the time elapsed between PD onset and the interview (O…

AdultMalemedicine.medical_specialtyParkinson's diseaseHypercholesterolemiaPopulationComorbidityWeight GainCoffeeBody Mass IndexRisk FactorsInternal medicineDiabetes mellitusWeight LossEpidemiologyDiabetes MellitusmedicineHumansObesityAge of OnseteducationAgedAged 80 and overHypertriglyceridemiaeducation.field_of_studybusiness.industrySmokingCase-control studynutritional and metabolic diseasesParkinson DiseaseMiddle AgedOverweightmedicine.diseaseNeurologyCase-Control StudiesHealthy individualsanthropometrical measures body mass index case–control study epidemiology Parkinson's disease risk factorsPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)businessBody mass index
researchProduct

Prevalence and incidence of multiple sclerosis in the city of Monreale, Italy

1997

The prevalence and incidence of multiple sclerosis (MS) in the city of Monreale, southern Italy were ascertained 10 years after a preliminary study in the same area. The study was undertaken in a population of 26,256 people. The patients were classified according to Poser’s criteria. The prevalence of MS on 31 December 1991 was 72.4 per 100,000 population. The incidence of MS for the period 1981–1991 was 3.3/100,000 per year. The mean period between onset and diagnosis of MS was 4.9 years for those patients found during this survey and 9.2 years for those in the first study. This study shows an increase of MS prevalence in Monreale city and a high incidence. The findings parallel the reduct…

AdultMalemedicine.medical_specialtyMultiple SclerosisAdolescentEpidemiologyPopulationAge DistributionLag timeEpidemiologyPrevalencemedicineHumansMultiple sclerosiSex DistributionChildeducationAgededucation.field_of_studybusiness.industryIncidenceMultiple sclerosisIncidence (epidemiology)Infant NewbornInfantMiddle Agedmedicine.diseaseHealth SurveysItalyNeurologyChild PreschoolSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessDemographyJournal of Neurology
researchProduct

Parkinson's disease and cancer: insights for pathogenesis from epidemiology .

2009

Epidemiological evidence suggests a reduced incidence of many common types of cancers in individuals with Parkinson's disease (PD). Parkinson's disease and cancer are two diseases that result from an excessive signaling by one of two forces driving cells to opposite directions. PD results from the excessive death of dopaminergic neurons in the substantia nigra pars compacta (SNc) in the brain, while uncontrolled growth is the key property of cancer. Parkinson's disease is a complex disorder, probably due in most of the cases to the interaction of environment and genes. Many genes responsible for familial forms of PD are supposed to have a supportive role in regulating or maintaining the cel…

Parkinson's diseaseCell Deathbusiness.industryPars compactaGeneral NeuroscienceIncidenceDopaminergicCancerSubstantia nigraParkinson DiseaseDiseaseCell cyclemedicine.disease_causemedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologySubstantia NigraHistory and Philosophy of ScienceRisk FactorsNeoplasmsMedicineHumansbusinessCarcinogenesisNeuroscienceAnnals of the New York Academy of Sciences
researchProduct

Height as a potential indicator of early life events predicting Parkinson's disease: A case-control study

2007

Aim of this study was to investigate the relationship between height in young adult age and Parkinson's disease (PD) risk. We included 266 persons affected by idiopathic PD. Patients were matched by age and sex to 266 controls by a random selection from the municipality of residence. We collected information about height preceding PD from official documents where these characteristics referred to young adult age (nearly 30 years). We compared height in cases and controls by calculating differences in mean distribution and by χ2 analyses. Crude and adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated by logistic regression models. Mean height was significantly lower in…

medicine.medical_specialtyPercentilebusiness.industryCase-control studyOdds ratioLogistic regressionConfidence intervalSurgeryNeurologyEpidemiologymedicineNeurology (clinical)Risk factorYoung adultbusinessDemographyMovement Disorders
researchProduct

Triiodothyronine accelerates the synthesis of synapsin I in developing neurons from fetal rat brain cultured in a synthetic medium.

1990

The effect of Triiodothyronine (T3) on Synapsin I appearance in rat cortical neurons has been investigated in vitro. Neuronal cultures from 16-day-old fetal rat brain grown in the absence of T3, express immunohystochemically detectable Synapsin I at the 14th day in vitro. The addition of the hormone to the culture medium determines an early (at the 7th day in vitro) appearance of fluorescent dots specific for Synapsin I. © 1990 Plenum Publishing Corporation.

Synapsin Imedicine.medical_specialtyCNS developmentCentral nervous systemFluorescent Antibody TechniqueNerve Tissue ProteinsBiologySettore BIO/19 - Microbiologia GeneraleBiochemistryCellular and Molecular NeuroscienceFetusInternal medicinemedicineAnimalschemically defined mediumimmunofluorescenceCells CulturedNeuronsFetusTriiodothyronineNeuroscience (all)BrainGeneral MedicineSynapsinsIn vitroCulture MediaRatsChemically defined mediummedicine.anatomical_structureEndocrinologynervous systemneuronal cultureCerebral cortexCell cultureTriiodothyronineSettore MED/26 - NeurologiaSynapsin 1Neurochemical research
researchProduct

Protective role of heat shock proteins in Parkinson's disease.

2010

Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease. Despite a large amount of research, the pathogenetic mechanism of these diseases has not yet been clarified. Abnormal protein folding, oxidative stress, mitochondrial dysfunction, and apoptotic mechanisms have all been reported as causes of neurodegenerative diseases in association with neuroinflammatory mechanisms which, by generating deleterious molecules, could promote the cascade of events leading to neurodegeneration. Heat shock proteins (HSPs) play a central role in preventing protein misfolding and inhibiting apoptotic activity, and represent a class of proteins potentially involve…

Heat shock proteins Parkinson disease neuroprotective roleParkinson's diseasebiologyNeurodegenerationParkinson DiseaseDiseasemedicine.diseasemedicine.disease_causeHsp90Hsp70PathogenesisNeurologyHeat shock proteinImmunologymedicinebiology.proteinAnimalsHumansHSP70 Heat-Shock ProteinsNeurology (clinical)HSP90 Heat-Shock ProteinsNeuroscienceOxidative stressHeat-Shock ProteinsNeuro-degenerative diseases
researchProduct

Prevalence of cervical spondylotic radiculopathy: A door-to-door survey in a Sicilian municipality

1996

Introduction - Because of the limited information on cervical spondylotic radiculopathy, we conducted a door-to-door two-phase survey in a Sicilian municipality. Material and methods - We first screened for cervical spondylotic radiculopathy among the inhabitants of the municipality : (N= 7653, as of the prevalence day, November 1, 1987). Study neurologists then investigated those subjects suspected to have had a cervical spondylotic radiculopathy. Diagnoses were based on specified criteria. Results - We found 27 subjects affected by CSR (17 definite, 10 possible). Prevalence (cases per 1000 population) was 3.5 in the total population ; it increased to a peak at age 50-59 years and decrease…

AdultMalemedicine.medical_specialtyAdolescentEpidemiologyCross-sectional studyPopulationTotal populationSpinal OsteophytosisRisk FactorsEpidemiologyPrevalencemedicineHumansMass ScreeningeducationChildSicilyMass screeningAgedAged 80 and overeducation.field_of_studyNeuroscience (all)business.industryIncidence (epidemiology)IncidenceNerve Compression SyndromesInfantGeneral MedicineMiddle Agedmedicine.anatomical_structureCross-Sectional StudiesNeurologyChild PreschoolCervical spondylotic radiculopathyPhysical therapyCervical VertebraePrevalence studiesSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessSpinal Nerve RootsDemographyCervical vertebrae
researchProduct

Implications for Estrogens in Parkinson's Disease: An Epidemiological Approach

2007

Abstract: Evidence from experimental and epidemiological studies suggests a role of sex hormones in the pathogenic process leading to neurodegenerative diseases, (i.e., Alzheimer's and Parkinson's disease). The effects of sexual steroid hormones are complex and vary with the events of women's fertile life. Estrogens are supposed to influence dopamine synthesis, metabolism, and transport; however, there is no consensus regarding the direction, locus, and mechanism of the effect of estrogens on the dopaminergic system. A neuroprotective effect of estrogens has been demonstrated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-animal models of Parkinson's disease (PD). Epidemiological st…

Malemedicine.medical_specialtyParkinson's diseaseMenopause PrematureDiseaseBioinformaticsNeuroprotectionGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundHistory and Philosophy of ScienceInternal medicinemedicineAnimalsHumansSex RatioLife lengthIncidenceGeneral NeuroscienceMPTPDopaminergicEstrogensParkinson Diseasemedicine.diseaseRatsMenopauseEndocrinologychemistryFemalePsychologyHormoneAnnals of the New York Academy of Sciences
researchProduct

Is season of birth associated with multiple sclerosis?

2000

Objective - To compare the monthly distribution of multiple sclerosis (MS) patients' births with that of the Sicilian population. Background -Studies on the association between season of birth and risk of MS are scanty and controversial. Design and methods - Archives of the Institute of Neuropsychiatry of the Universities of Palermo and Catania were searched up to 1995 for definite MS patients (McDonald & Halliday criteria). The monthly distribution of MS patients' births (N=965) was compared with that of the Sicilian population (N = 5,608,307). Results -The distribution of births among MS patients compared with the general population was not different when tested by the X 2 statistic (P > …

education.field_of_studymedicine.medical_specialtyMonth of birthSeason of birthbusiness.industryMultiple sclerosisPopulationGeneral Medicinemedicine.diseaseSurgeryNeurologyEpidemiologyMedicineNeurology (clinical)Risk factorbusinesseducationDemographyActa Neurologica Scandinavica
researchProduct

Treatment of multiple sclerosis with interferon beta in clinical practice: 2-year follow-up data from the South Italy Mobile MRI Project.

2006

This follow-up study assessed the 2-year clinical and magnetic resonance imaging (MRI) outcomes of patients with multiple sclerosis (MS) originally enrolled in an MRI study conducted at eight centres in south Italy (the South Italy Mobile MRI Project). Of the 597 MS patients recruited at baseline, 391 returned for the follow-up study. Of these, 363 provided 2-year clinical and MRI follow-up data, and 215 were still undergoing treatment with one of four interferon beta regimens: Avonex, 30 mcg intramuscularly once weekly; Betaferon, 250 mcg subcutaneously (sc) every other day; Rebif 22 mcg sc three times weekly (tiw; Rebif 22); or Rebif 44 mcg sc tiw (Rebif 44). Over the 2-year follow-up per…

medicine.medical_specialtyNeurologyMultiple SclerosisDermatologySeverity of Illness IndexInterferon beta • Multiple sclerosis • Phase IV • Odds ratioInternal medicineSeverity of illnessmedicineConfidence IntervalsHumansImmunologic FactorsMultiple sclerosiNeuroradiologyAnalysis of Variancemedicine.diagnostic_testbusiness.industryMultiple sclerosisMagnetic resonance imagingGeneral MedicineOdds ratioInterferon-betaOdds ratiomedicine.diseaseInterferon betaMagnetic Resonance ImagingConfidence intervalPsychiatry and Mental healthItalyPhysical therapySettore MED/26 - NeurologiaNeurology (clinical)NeurosurgeryPhase IVbusinessFollow-Up Studies
researchProduct

Motor intracortical inhibition in PD: L-DOPA modulation of high-frequency rTMS effects

2007

Dopaminergic drugs and deep brain stimulation restore cortical inhibition in Parkinson disease (PD) patients. High-frequency rTMS was also found to increase cortical inhibition in PD but its therapeutic effect is still controversial. Here we hypothesize that, if dopaminergic drugs reverse to normal cortical excitability in M1, the effect of high-frequency (hf)-rTMS in PD patients could depend on whether they are in a medicated or unmedicated state. The present study aims to explore the lasting effects of sub-threshold hf rTMS trains over M1 on cortical inhibition in patients with "on" and without "off" L-DOPA treatment. Fourteen PD patients were examined twice while "on" and "off" medicatio…

Malemedicine.medical_specialtyNeurologyDeep brain stimulationCORTICAL SILENT PERIODmedicine.medical_treatmentStimulationMotor ActivityInhibitory postsynaptic potentialPAIRED-PULSE INHIBITIONAntiparkinson AgentsLevodopaDegenerative diseaseEVOKED-POTENTIALSmedicineHumansCORTEX EXCITABILITYAgedAged 80 and overSUBTHALAMIC NUCLEUSPARKINSONS-DISEASE PATIENTSGeneral NeuroscienceDopaminergicMotor CortexNeural InhibitionParkinson DiseaseMiddle Agedmedicine.diseaseFACILITATIONCombined Modality TherapyTranscranial Magnetic StimulationTranscranial magnetic stimulationBRAIN-STIMULATIONmedicine.anatomical_structureSettore MED/26 - NeurologiaFemaleREPETITIVE TMSPsychologyNeuroscienceMotor cortexExperimental Brain Research
researchProduct

Intravenous gammaglobulin treatment in chronic progressive multiple sclerosis

1998

Progressive multiple sclerosismedicine.medical_specialtyPediatricsNeurologyNeuroscience (all)business.industryGeneral NeuroscienceMultiple sclerosisIntravenous gammaglobulinDermatologyGeneral Medicinemedicine.diseasePsychiatry and Mental healthmedicineChronic progressive multiple sclerosisSettore MED/26 - NeurologiaNeurosurgeryNeurology (clinical)businessNeuroradiology
researchProduct

Effects of More-Affected vs. Less-Affected Motor Cortex tDCS in Parkinson’s Disease

2017

Objective. To evaluate therapeutic potential of different montages of transcranial direct current stimulation (tDCS) in Parkinson’s Disease (PD) patients with asymmetric motor symptoms. Materials and Methods. Fourteen patients with asymmetric PD underwent, while on treatment, seven separate sessions including electrophysiological and clinical evaluation at baseline and after anodal, cathodal and sham tDCS of the primary motor cortex (M1) of the two hemispheres. Changes in motor cortical excitability were evaluated by transcranial magnetic stimulation. Effects on motor symptoms were assessed by testing finger tapping and upper limb bradykinesia, and by using the Italian validated Movement Di…

0301 basic medicinemedicine.medical_specialtynon-invasive brain stimulationParkinson's diseaseNeurologymedicine.medical_treatmenttDCSlcsh:RC321-57103 medical and health sciencesBehavioral Neuroscience0302 clinical medicinePhysical medicine and rehabilitationmotor cortexmedicineParkinsonâ s diseaselcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBiological PsychiatryOriginal ResearchTranscranial direct-current stimulationcortical excitabilitymedicine.diseaseTranscranial magnetic stimulationElectrophysiology030104 developmental biologymedicine.anatomical_structureNeuropsychology and Physiological PsychologyNeurologyPsychiatry and Mental HealthFinger tappingParkinson’s diseaseSettore MED/26 - NeurologiaPrimary motor cortexPsychologyNeuroscience030217 neurology & neurosurgeryMotor cortexCortical excitability; Motor cortex; Non-invasive brain stimulation; Parkinson’s disease; tDCS; Neuropsychology and Physiological Psychology; Neurology; Psychiatry and Mental Health; Biological Psychiatry; Behavioral NeuroscienceNeuroscienceFrontiers in Human Neuroscience
researchProduct

Interobserver Agreement in the Diagnosis of Multiple Sclerosis

1989

• Interobserver agreement in the clinical diagnosis of multiple sclerosis (MS) among six neurologists was evaluated. Three of them participated in a study of the clinical diagnosis of MS, the Italian Multicenter Study (IMS). The raters examined the clinical forms of MS of 50 patients randomly selected from among 430 patients recruited from the IMS. For each patient, neurologists were asked to make a diagnosis according to the McDonald-Halliday classification system of MS. The overall agreement on the diagnosis (MS present or absent) was fair, with no difference noted between the two groups of raters. Considering the six diagnostic levels instead, the reliability was higher for the neurologi…

AdultMalePediatricsmedicine.medical_specialtyMultiple Sclerosisbusiness.industryMultiple sclerosisMethodDiseasemedicine.diseaseSurgeryClinical trialArts and Humanities (miscellaneous)Multicenter studyClinical diagnosisMultiple SclerosiMethodsmedicineHumansFemaleNeurology (clinical)businessReliability (statistics)HumanArchives of Neurology
researchProduct

The parkin gene is not a major susceptibility locus for typical late-onset Parkinson's disease

2001

We investigated the parkin gene in 118 patients with typical Parkinson's disease (PD), i. e. in patients who had an onset of PD after the age of 45 years. The study group included 95 subjects with sporadic PD and 23 subjects from 18 families with autosomal recessive PD. No pathogenetic mutations in the parkin gene were detected either in familial or in sporadic patients. Our findings indicate that the parkin gene is not involved in the pathogenesis of classic late-onset PD.

Malemedicine.medical_specialtyNeurologyParkinson's diseaseUbiquitin-Protein LigasesDNA Mutational AnalysisMolecular Sequence DataLate onsetGenes RecessiveDermatologyDiseaseParkinPathogenesisLigasesParkinsonian DisordersmedicineHumansPoint MutationGenetic Predisposition to DiseaseGenetic TestingAge of OnsetAgedGeneticsbusiness.industryGeneral MedicineExonsParkin geneMiddle Agedmedicine.diseasenervous system diseasesPsychiatry and Mental healthSusceptibility locusChromosomes Human Pair 6FemaleNeurology (clinical)business
researchProduct

Selective culture of rat CNS neurons in a synthetic medium.

1983

A Chemically Defined Medium is described which facilitates the survival of neurons in primary cultures of rat cerebral hemispheres. More than 90% of all cells were identified as neurons using neurofilament as a marker in an immunocytochemical assay. In contrast, serum-supplemented medium, by stimulating nonneuronal cell proliferation, hinders the survival of neurons in culture.

NeuronsNonneuronal cellNeurofilamentGeneral NeuroscienceBrainDermatologyGeneral MedicineBiologyEmbryo MammalianCell biologyCulture MediaRatsPsychiatry and Mental healthChemically defined mediumnervous systemCell cultureAnimalsNeurology (clinical)NeurogliaCells CulturedItalian journal of neurological sciences
researchProduct

Door-to-Door Prevalence Survey of Neurological Diseases in a Sicilian Population

1991

In three municipalities of Sicily, a prevalence survey of major neurological diseases was conducted door-to-door using screening and examination to find cases. This was the first large-scale neuroepid

medicine.medical_specialtyPediatricseducation.field_of_studyEpidemiologybusiness.industryPopulationPrevalence surveylanguage.human_languageFamily medicinemedicinelanguageNeurology (clinical)educationbusinessSicilianNeuroepidemiology
researchProduct

A further study on the prevalence of multiple sclerosis in Sicily: Caltanissetta city

2009

– The prevalence of probable multiple sclerosis (MS) in Caltanissetta city, Sicily, is at least 51 per 100,000. If possible multiple sclerosis patients are included, it is 54 per 100,000. This value is similar to that found in other cities in Sicily: Enna, Monreale and Agrigento. The high prevalence of multiple sclerosis in Caltanissetta confirms the previous data on Sicily and emphasises the importance of small population studies in the epidemiology of MS.

AdultMalemedicine.medical_specialtyMultiple SclerosisAdolescentUrban PopulationPopulationEpidemiologymedicineHumansNeuroepidemiologyeducationSicilyeducation.field_of_studyHigh prevalenceMultiple sclerosisAge FactorsGeneral MedicineMiddle Agedmedicine.diseaseGeographyItalyNeurologyFemaleNeurology (clinical)DemographyActa Neurologica Scandinavica
researchProduct

Frequency and determinants for hemorrhagic transformation of cerebral infarction.

2009

&lt;i&gt;Background:&lt;/i&gt; Frequency and associated risk factors for hemorrhagic transformation (HT), a worrying complication of ischemic stroke (IS), are not clearly defined. Our aim was to estimate the overall frequency and risk factors for HT in a hospital-based population. &lt;i&gt;Methods:&lt;/i&gt; A retrospective review of medical records of patients discharged from our department during the period 2004–2006 with a diagnosis of anterior IS. Demographic, clinical and hematological information was collected. Uni- and multivariate logistic regression analyses were used to estimate risk for spontaneous HT. &lt;i&gt;Results:&lt;/i&gt; We included 240 patients (125 males, 52%), mean ag…

Malemedicine.medical_specialtyTime FactorsEpidemiologyMEDLINEText miningRisk FactorsEpidemiologyMedicineHumansAgedCerebral HemorrhageRetrospective StudiesAged 80 and overhemorrhagic transformation ischemic strokebusiness.industryCerebral infarctionFollow up studiesRetrospective cohort studyCerebral InfarctionMiddle Agedmedicine.diseaseSurgeryEmergency medicineIschemic strokeFemaleNeurology (clinical)businessComplicationFollow-Up Studies
researchProduct

Incidence of multiple sclerosis in Bagheria City, Sicily, Italy.

2001

We investigated the incidence of multiple sclerosis (MS) in a Sicilian community located at sea level. The study was a retrospective search for MS patients. Incidence was studied in the period from 1 January 1985 to 31 December 1994. We searched for definite MS patients, according to Poser's criteria, among the population resident in Bagheria (Palermo province). There were 25 subjects affected by MS, of which 20 were incident MS patients. The average annual incidence was 4.4 per 100 000 persons (n = 453 385 person-years). The incidence increased over time (1985-1989 = 3.5, 1990-1994 = 5.3). A parallel decrease of the interval between onset and diagnosis of MS was observed (1985-1989, 3.7 ye…

AdultMalemedicine.medical_specialtyPediatricsMultiple SclerosisAdolescentEpidemiologyPopulationDermatologyAnnual incidenceCohort StudiesEpidemiologymedicinePrevalenceHumansMultiple sclerosieducationSicilyRetrospective Studieseducation.field_of_studyNeuroscience (all)business.industryMultiple sclerosisIncidence (epidemiology)IncidenceGeneral MedicineMiddle Agedmedicine.diseaselanguage.human_languagePsychiatry and Mental healthCross-Sectional StudieslanguageSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessSicilianNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Myasthenia-like syndrome induced by cardiovascular agents. Report of a case

1987

The case of a myasthenia-like syndrome induced by cardiovascular drugs is reported. The clinical and electrophysiological features of the case are discussed. © 1987 Masson Italia Periodici S.r.l.

Malemedicine.medical_specialtyNeurologyNeuromuscular JunctionCoronary DiseaseDermatologyPeruvosideMyasthenia-like syndromeSynaptic TransmissionPropafenoneimmune system diseasesMyasthenia GravisHumansMedicineperuvosideEtafenone hydrochlorideAgedNeuroradiologyOphthalmoplegiaNeuroscience (all)business.industryGeneral NeuroscienceGeneral Medicinenervous system diseasesCardenolidesPsychiatry and Mental healthAnesthesiaCardiovascular agentetafenone hydrochlorideDrug Therapy CombinationSettore MED/26 - NeurologiaNeurosurgeryNeurology (clinical)businessmedicine.drug
researchProduct

A novel mutation of the extracellular matrix protein 1 gene (ECM1) in a patient with lipoid proteinosis (Urbach-Wiethe disease) from Sicily

2005

Summary Background  Lipoid proteinosis (LP), also known as Urbach–Wiethe disease, is a rare autosomal recessive disorder characterized by a hoarse voice, warty skin infiltration and scarring. Mutations within the extracellular matrix protein 1 (ECM1) gene cause LP. Objectives  We report the molecular analysis of the ECM1 gene in a Sicilian patient with LP in order to extend the mutation spectrum of this genodermatosis. Methods  We studied a 32-year-old female born from consanguineous parents who was diagnosed at the age of 11 years as having LP. She has a clinical phenotype corresponding to Urbach–Wiethe disease characterized by papules/nodules, indurated plaques and sometimes ulcerated les…

AdultPathologymedicine.medical_specialtySettore MED/09 - Medicina InternaBiopsyMolecular Sequence DataNonsense mutationDermatologyBiologyUrbach–Wiethe diseasemedicine.disease_causePolymerase Chain ReactionFrameshift mutationExtracellular matrix protein 1ExonmedicineHumanseducationSicilyGeneExtracellular Matrix Proteinseducation.field_of_studyMutationBase SequenceGenodermatosisSkin Diseases Geneticmedicine.diseasePedigreeECM1 gene lipoid proteinosis mutationSettore MED/03 - Genetica MedicaCodon NonsenseLipoid Proteinosis of Urbach and WietheSettore MED/26 - NeurologiaFemaleBritish Journal of Dermatology
researchProduct

The relapse rate of multiple sclerosis changes during pregnancy: a cohort study

2004

Objective – To evaluate the influence of pregnancy and puerperium on the relapse rate of multiple sclerosis (MS). Methods – We determined retrospectively the yearly mean relapse rate (MRR) during pregnancies occurring in the course of relapsing–remitting MS. We compared the MRR of pregnancy-time with that of non-pregnancy time by paired t-test. Relative risk (RR) of relapses during the pregnancy-time was also compared with that of non-pregnancy time by χ2 analysis and 95% confidence intervals. Results – From a population of 351 women affected by clinically definite MS, only 70 reported pregnancies during their relapsing–remitting phase of MS for a total of 98 pregnancies. Both MRR (P = 0.00…

Adultmedicine.medical_specialtyAdolescentPopulationComorbidityCohort StudiesMultiple Sclerosis Relapsing-RemittingPregnancyRecurrenceRisk FactorsHumansMedicinepuerperiumeducationRetrospective Studieseducation.field_of_studyPregnancybiologybusiness.industryObstetricsMultiple sclerosisGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationConfidence intervalSurgeryPregnancy ComplicationsItalyNeurologymultiple sclerosiRelative riskTasaPregnancy in AdolescenceGestationFemaleNeurology (clinical)relapse ratebusinessCohort studyActa Neurologica Scandinavica
researchProduct

The dynamic properties of neuronal chromatin are modulated by triiodothyronine.

1992

The effect of triiodothyronine (T3) on the rate of synthesis of nuclear proteins was studied during terminal differentiation of rat cortical neurons cultured in a serum-free medium. To this aim total and acid soluble nuclear proteins were analyzed by different electrophoretic techniques. Our results show that: 1) during maturation in vitro, neuronal nuclei undergo a dramatic change in the rate at which different classes of histones and high mobility group (HMG) proteins are synthesized; the synthetic activity, measured as incorporation of radioactive precursors into nuclear proteins, slows indeed down with age: especially evident is the decrease in core histones synthesis; at day 15, on the…

CNS developmentLysineBiologyBiochemistryCellular and Molecular NeuroscienceSettore BIO/10 - BiochimicamedicineAnimalsSettore BIO/06 - Anatomia Comparata E CitologiaNuclear proteinCells CulturedNeuronsTriiodothyronineLysineGeneral MedicineneuronChromatinChromatinCell biologyRatsCell nucleusmedicine.anatomical_structureHigh-mobility groupHistoneBiochemistrySolubilitybiology.proteinTriiodothyronineSettore MED/26 - NeurologiaElectrophoresis Polyacrylamide GelNeuronNeurochemical research
researchProduct

Frequency and determinants for hemorrhagic transformation of posterior cerebral stroke

2017

Abstract Background hemorrhagic transformation is a threatening ischemic stroke complication. Frequency of hemorrhagic transformation differs greatly among studies, and its risk factors have been usually studied in patients with anterior ischemic stroke who received thrombolytic therapy. We evaluated, in a hospital-based series of patients with posterior ischemic stroke not treated with thrombolysis, frequency and risk factors of hemorrhagic transformation. Patients with posterior circulation stroke were seen in our Department during the period January 2004 to December 2009. Demographic and clinical information were collected. We estimated risk for spontaneous hemorrhagic transformation by …

Aged 80 and overMaleHemorrhagic transformationEpidemiologylcsh:Rlcsh:MedicineBrain IschemiaStrokelcsh:Biology (General)Posterior ischemic strokeRisk FactorsHumansFemalelcsh:Science (General)lcsh:QH301-705.5lcsh:Q1-390Research ArticleAgedCerebral HemorrhageBMC Research Notes
researchProduct

Incidence of amyotrophic lateral sclerosis in Sicily: A population based study

2012

Our objective was to investigate incidence of amyotrophic lateral sclerosis (ALS) in Sicily, southern Italy, by means of a population based study. We included people with ALS resident in fi ve Sicilian provinces, whose onset occurred in the two-year period 2005 2006 (population at 31 December 2006: 3,481,096 inhabitants). A multisource case-fi nding procedure was adopted and patients were classifi ed as affected by ALS according to revised El Escorial criteria. During the two-year surveillance period, 97 patients meeting eligibility criteria included 57 males (58.8%) and 40 females (41.2%). Crude annual incidence rate was 1.4/100,000 person years (95% CI 1.33 1.47). The incidence rate was h…

AdultMaleGerontologymedicine.medical_specialtyAdolescentPopulationPrevalenceYoung AdultAge DistributionEpidemiologymedicineHumanssicilyamyotrophic lateral sclerosiYoung adultAmyotrophic lateral sclerosisChildeducationAgedAged 80 and overSex Characteristicseducation.field_of_studybusiness.industryIncidence (epidemiology)Amyotrophic Lateral SclerosisInfantGeneral MedicineMiddle Agedmedicine.diseasepopulation-basedPopulation based studyItalyNeurologyamyotrophic lateral sclerosis; incidence; epidemiology; population-based; sicilyChild PreschoolincidenceFemaleepidemiologySettore MED/26 - NeurologiaNeurology (clinical)businessDemographySex characteristicsAmyotrophic Lateral Sclerosis
researchProduct

NEURONS PRODUCE FGF-2 AND VEGF SECRETE THEM AT LEST IN PART BY SHEDDING EXTRACELLULAR VESCICLES

2007

Abstract We previously found that neurons are able to affect the ability of brain capillary endothelial cells to form in vitro a monolayer with properties resembling the blood-brain barrier. We then looked, by immunofluorescence and western analysis, for factors, produced by neurons, with the potential to influence growth and differentiation of endothelial cells. In the present paper, we report that neurons produce both vascular endothelial growth factor and fibroblast growth factor 2, two well-known angiogenic factors. More interestingly, we gained evidence that both factors are released by neurons, at least in part, by shedding of extracellular vesicles, that contain β1 integrin, a membra…

Vascular Endothelial Growth Factor AFGF-2BiologyFibroblast growth factorchemistry.chemical_compoundsheddingNeurofilament ProteinsGlial Fibrillary Acidic ProteinExtracellularAnimalsSecretionRats WistarCells CulturedNeuronsVesicleIntegrin beta1Secretory VesiclesCell BiologyArticlesVEGFTransport proteinCell biologyRatsVascular endothelial growth factorVascular endothelial growth factor AProtein TransportMembrane proteinchemistryAstrocytesMolecular Medicineneurons vesicles fibroblastic growth factor-2 vascular endothelial growth factorCamptothecinFibroblast Growth Factor 2Extracellular Spaceextracellular vesicles
researchProduct

Myasthenia gravis associated with Charcot-Marie-Tooth neuropathy: report of a case

1992

We report the case of a 24 year old woman who developed myasthenia gravis in the course of a mild form of Charcot-Marie-Tooth neuropathy. We describe the clinical manifestations together with the neurophysiological, pathological, serological findings and response to therapy and discuss the unusual association in the light of the relevant literature. © 1992 Masson Italia Periodici S.r.l.

Adultmedicine.medical_specialtyNeurologyResponse to therapySural nerve biopsySural NerveCharcot-Marie-Tooth DiseaseMyasthenia GravismedicineHumansReceptors CholinergicMild formPathologicalsural nerve biopsyNeuroscience (all)business.industryGeneral Neuroscienceanti-acetylcholine receptor antibodiemedicine.diseaseDermatologymyasthenia graviMyasthenia gravisSurgeryFemaleSettore MED/26 - NeurologiaNeurosurgeryNeurology (clinical)businessCharcot-Marie-Tooth neuropathy
researchProduct

Mercaptopurine Treatment in an Adult Man with Orbital and Intracranial Rosai-Dorfman Disease.

2016

Background. Rosai-Dorfmann disease (RDD) is a rare, idiopathic non-Langerhans cell histiocytosis, affecting children and young adults, that commonly presents as painless, massive cervical lymphadenopathy with fever, weight loss, and polyclonal hypergammaglobulinemia. Cervical lymphadenopathy and extranodal involvement are the main presentations. On the contrary, ophthalmic involvement and localisation in the central nervous system are rare.Case Report. An old man was admitted to our hospital for first seizure. Brain imaging studies revealed on the left an extra-axial thickening of the dura mater with enhancement and perilesional oedema, infiltrating the sphenoorbital fissure and an isointen…

medicine.medical_specialtyPathologyDura materRosai-Dorfmann disease mercaptopurine treatmentCase Reportlcsh:RC346-42903 medical and health sciences0302 clinical medicineCervical lymphadenopathymedicineExtranodal Involvementlcsh:Neurology. Diseases of the nervous systemRosai–Dorfman diseasebusiness.industrymedicine.diseaseDebulkingMercaptopurineHistiocytosismedicine.anatomical_structure030220 oncology & carcinogenesisOptic nerveRadiologymedicine.symptomGeneral Agricultural and Biological Sciencesbusiness030217 neurology & neurosurgerymedicine.drug
researchProduct

Multiple Sclerosis in Southern Europe: Monreale City, Italy

2004

&lt;i&gt;Background:&lt;/i&gt; Several follow-up studies showed increasing prevalence and incidence rates for multiple sclerosis (MS). &lt;i&gt;Objective:&lt;/i&gt; To ascertain, throughout a follow-up study, the incidence and prevalence of MS in the city of Monreale, Sicily, southern Italy. &lt;i&gt;Methods:&lt;/i&gt; We calculated crude and age- and sex-specific prevalence rates on December 31, 2000, and determined incidence rates for the period January 1, 1992 to December 31, 2000. &lt;i&gt;Results:&lt;/i&gt; The prevalence of MS was 71.2 per 100,000 population (48,5/100,000 in men; 93,0/100,000 in women). The incidence rate of MS for the period 1992–2000 was 4.0/100,000 per year. &lt;i&…

Pediatricsmedicine.medical_specialtyEpidemiologybusiness.industryMultiple sclerosisIncidence (epidemiology)medicinemacromolecular substancesNeurology (clinical)medicine.diseasebusinessNeuroepidemiology
researchProduct

Functional feature of a novel model of blood brain barrier: Studies on permeation of test compounds

2001

Drug delivery to the central nervous system (CNS) is subject to the permeability limitations imposed by the blood-brain barrier (BBB). Several systems in vitro have been described to reproduce the physical and biochemical behavior of intact BBB, most of which lack the feature of the in vivo barrier. We developed a fully formed monolayer of RBE4.B immortalized rat brain microvessel endothelial cells (ECs), grown on top of polycarbonate filter inserts with cortical neuronal cells grown on the outside. Neurons induce ECs to synthesize and sort occludin to the cell periphery. Occludin localization is regulated by both compositions of the substratum and soluble signals released by cortical co-cu…

DopamineL-DOPAPharmaceutical ScienceBrain capillaries endothelial cells (ECs)OccludinBlood–brain barrierDopamine agonistPermeabilityLevodopaRats Sprague-DawleyDopamineIn vivoSettore BIO/10 - BiochimicamedicineAnimalsCells CulturedChemistryTryptophanPermeationRatsEndothelial stem cellBlood-brain barrier (BBB)medicine.anatomical_structureBiochemistryPermeability (electromagnetism)Blood-Brain BarrierSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBiophysicsSettore MED/26 - Neurologiamedicine.drugL-Tryptophan
researchProduct

Tumor diagnosis preceding Parkinson's disease: A case-control study

2004

Lower cancer risk in Parkinson's disease (PD) patients compared to the general population has been reported. However, most of the studies were based on death certificates. We designed a case–control study to estimate the association of tumor preceding PD onset and PD. PD patients were matched by age and gender to PD-free individuals, randomly selected from the municipalities of residence of cases. Occurrence of tumors preceding PD onset was assessed through a structured questionnaire. Neoplasms were categorized as benign, malignant, or of uncertain classification, and endocrine-related or not. Odds ratios (OR) were calculated using conditional logistic regression and adjusted for tumor cate…

medicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationCase-control studyCancerOdds ratioDiseasemedicine.diseaseConfidence intervalSurgeryCentral nervous system diseaseNeurologyInternal medicineEpidemiologyMedicineNeurology (clinical)businesseducationMovement Disorders
researchProduct

Parkinson disease survival: a population-based study

2000

Objective To evaluate whether the survival of patients with Parkinson disease (PD) is shorter than that of the general population. Design Survival was investigated in a cohort of patients with PD previously identified during a population-based prevalence study (prevalence day, November 1, 1987; reference follow-up date, October 31, 1995). The survival of patients with PD was compared with that of a control sample randomly selected from the same population (2 controls for each case, matched for age, sex, and study municipality). The causes of death in the 2 groups were also compared. Both univariate and multivariate survival analyses were performed to investigate the association with disease…

Malemedicine.medical_specialtyMultivariate analysisHeart DiseasesPopulationComorbidityCohort StudiesLevodopaAge DistributionArts and Humanities (miscellaneous)Internal medicineCause of DeathmedicinePrevalenceHumansSex DistributioneducationSurvival rateSicilySurvival analysisCause of deathAgedProportional Hazards ModelsAged 80 and overUnivariate analysiseducation.field_of_studyNeuroscience (all)Proportional hazards modelbusiness.industryParkinson DiseasePneumoniaMiddle AgedSurvival AnalysisSurgerySurvival RateMultivariate AnalysisSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessCohort study
researchProduct

Prevalence of essential tremor: A door-to-door survey in Terrasini, Sicily

1994

As part of a door-to-door neuroepidemiologic survey, we investigated the frequency and distribution of essential tremor (ET) in a Sicilian municipality. During phase 1, we administered a screening instrument for tremor to 7,653 persons residing in Terrasini (Palermo province). During phase 2, neurologists evaluated those subjects who had screened positive. The diagnoses, based on specified clinical criteria, were reviewed to increase reliability across neurologists. We found 31 subjects affected by ET (17 men, 14 women); 11 patients (35.5%) reported a familial aggregation. The prevalence of ET as of November 1, 1987, was 405.1 per 100,000 for the total population, and 1,074.9 per 100,000 fo…

medicine.medical_specialtyEssential tremorbusiness.industryFamily aggregationGeographic variationNeurological disorderTotal populationmedicine.diseaseSex factorsEpidemiologymedicineNeurology (clinical)businessScreening instrumentDemographyNeurology
researchProduct

Leprosy: report of a case with severe peripheral neuropathy

2009

Leprosy (Hansen's disease) is a chronic granulomatous infectious disease, caused by Mycobacterium leprae, with cutaneous and neurological manifestations. Leprosy is very rare in Europe but some cases are reported, especially among people coming from endemic areas. Here, we report a case of Hansen's disease and emphasize the importance of a prompt diagnosis and treatment also in non-endemic areas.

Malemedicine.medical_specialtyNeurologyAdolescentSensory Receptor CellsChronic granulomatousLeprosy neuropathyNeural ConductionDermatologyDiseaseLeprosymedicineHumansMuscle SkeletalSicilyMycobacterium lepraeMotor NeuronsbiologyElectromyographybusiness.industryPeripheral Nervous System DiseasesGeneral Medicinebiology.organism_classificationmedicine.diseaseDermatologySenegalPsychiatry and Mental healthPeripheral neuropathyInfectious disease (medical specialty)ImmunologySettore MED/26 - NeurologiaNeurology (clinical)LeprosyNeurosurgerybusinessNeurological Sciences
researchProduct

A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis

2002

Objective To investigate the efficacy of two different high doses of intravenous methylprednisolone (IVMP) during Multiple Sclerosis (MS) relapses. Background Transcranial Magnetic Stimulation (TMS) is the most sensitive neurophysiological ascertainment to quantify motor disability, to follow the recovery from an MS relapse, and to detect the response to treatment. Design and method Twenty-four clinically definite relapsing - remitting MS patients presenting a relapse were randomly assigned to a treatment for 5 days with IVMP 1 or 2 g/day. The response to treatment of each patient was evaluated through Expanded Disability Status Scale (EDSS), Medical Research Council (MRC) score, and TMS by…

medicine.medical_specialtyExpanded Disability Status Scalemedicine.diagnostic_testbusiness.industryMultiple sclerosismedicine.medical_treatmentMagnetic resonance imagingGeneral Medicinemedicine.diseaselaw.inventionSurgeryTranscranial magnetic stimulationNeurologyRandomized controlled trialMethylprednisolonelawAnesthesiamedicineSilent periodNeurology (clinical)Evoked potentialbusinessmedicine.drugActa Neurologica Scandinavica
researchProduct

Permeability properties of a three-cell type in vitro model of blood-brain barrier.

2005

We previously found that RBE4.B brain capillary endothelial cells (BCECs) form a layer with blood‐brain barrier (BBB) properties if co‐cultured with neurons for at least one week. As astrocytes are known to modulate BBB functions, we further set a culture system that included RBE4.B BCECs, neurons and astrocytes. In order to test formation of BBB, we measured the amount of (3)H‐sucrose able to cross the BCEC layer in this three‐cell type model of BBB. Herein we report that both neurons and astrocytes induce a decrease in the permeability of the BCEC layer to sucrose. These effects are synergic as if BCECs are cultured with both neurons and astrocytes for 5 days, permeability to sucrose decr…

SucroseCell typeTime FactorsBlotting WesternVascular permeabilityBiologyBlood–brain barrierOccludinArticleCapillary PermeabilityOccludinmedicineAnimalsRats WistarCell Line TransformedNeuronsBrainEndothelial CellsMembrane ProteinsCell BiologyPermeationblood-brain barrier cortical neurons astrocytes brain capillary endothelial cells RBE4.B occludin.Coculture TechniquesRatsmedicine.anatomical_structurenervous systemMembrane proteinBiochemistryBlood-Brain BarrierPermeability (electromagnetism)Astrocytescardiovascular systembiology.proteinBiophysicsMolecular MedicineAntibody
researchProduct

Apolipoprotein E genotype does not influence the progression of multiple sclerosis

2003

OBJECTIVE: To investigate the association between apolipoprotein E (APOE) polymorphisms and the progression of MS. METHODS: We investigated 428 subjects affected by clinically defined MS, with a disease duration of at least three years. We collected data concerning the age at onset of MS, clinical type, disease duration and disability according to the expanded disability status scale (EDSS). We also calculated the progression index (PI) to evaluate disease progression. APOE genotyping and the -491 A/T polymorphism of the APOE promoter were determined. RESULTS: No association was observed between the APOE epsilon4 allele and clinical characteristics of our study population. We also investiga…

OncologyApolipoprotein EAdultMalemedicine.medical_specialtyMultiple SclerosisGenotypeAdolescentOdds Ratio; Polymorphism Genetic; Chi-Square Distribution; Humans; Disease Progression; Apolipoproteins E; Genotype; Multiple Sclerosis; Adult; Confidence Intervals; Adolescent; Statistics Nonparametric; Female; MalePopulationAPOE polymorphismBiologyStatistics NonparametricApolipoproteins EGeneticPolymorphism (computer science)Internal medicineGenotypeMultiple SclerosimedicineOdds RatioConfidence IntervalsHumansNonparametricPolymorphismeducationGenotypingAPOE promotereducation.field_of_studyExpanded Disability Status ScalePolymorphism GeneticChi-Square DistributionMS progressionStatisticsOdds ratioNeurologyImmunologyDisease ProgressionPopulation studylipids (amino acids peptides and proteins)FemaleSettore MED/26 - NeurologiaNeurology (clinical)Confidence IntervalHuman
researchProduct

The pharmacovigilance program on natalizumab in Italy: 2 years of experience.

2009

At the end of 2006 a country-based surveillance program on natalizumab therapy in multiple sclerosis was settled in Italy by a collaborative effort of the Italian Drug Agency (AIFA) and a group of experts and neurologists appointed by the National Society of Neurology (SIN). After 2 years, 1,818 patients are registered in the database. The majority of cases (88.6%) failed the therapy with beta interferon or glatiramer acetate and had relapses or accumulated disability during immunomodulating treatment, while 11.4% of patients enrolled in the surveillance study were not previously treated with immunomodulating therapies and had a rapidly evolving clinical course. Almost 10% of the patients t…

AdultMalemedicine.medical_specialtyPediatricsNeurologyMultiple SclerosisPatient DropoutsDatabases FactualAlternative medicineDermatologyPharmacologyAntibodies Monoclonal HumanizedNatalizumabPharmacovigilanceProduct Surveillance PostmarketingMedicineHumansGlatiramer acetateMultiple sclerosis NatalizumabSurveillance programPharmacovigilancebusiness.industryMultiple sclerosisNatalizumabAntibodies MonoclonalDrug agencyGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingPsychiatry and Mental healthItalyPHARMACOVIGILANCEREGISTRYSettore MED/26 - NeurologiaFemaleNeurology (clinical)Neurosurgerybusinessmedicine.drugFollow-Up StudiesNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Early and late mortality of spontaneous hemorrhagic transformation of ischemic stroke.

2014

Background Hemorrhagic transformation (HT), a complication of ischemic stroke (IS), might influence patient's prognosis. Our aim is to evaluate, in a hospital-based series of patients not treated with thrombolysis, the relationship between HT and mortality. Methods We compared mortality of individuals with spontaneous HT with that of individuals without. Medical records of patients diagnosed with anterior IS were retrospectively reviewed. Outcome measures were 30- and 90-day survival after IS onset. Kaplan–Meier estimates were used to construct survival curves. Cox proportional hazards model was used to estimate hazard ratio (HR) for the main outcome measure (death). HT was stratified in he…

Malemedicine.medical_specialtysurvivalBrain IschemiaCohort StudiesHematomaRisk FactorsInternal medicineMedicineHumansStrokeSurvival analysisAgedRetrospective StudiesAged 80 and overIschemic strokeAspirinbusiness.industryProportional hazards modelHeparinMortality rateRehabilitationHazard ratioAnticoagulantsIschemic stroke; epidemiology; hemorrhagic transformation; prognosis; survivalMiddle Agedmedicine.diseaseConfidence intervalSurgeryStrokeSurvival Ratehemorrhagic transformationCardiologyDisease ProgressionepidemiologySettore MED/26 - NeurologiaSurgeryFemaleNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessComplicationIntracranial HemorrhagesprognosiPlatelet Aggregation InhibitorsFollow-Up StudiesJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
researchProduct

Expression of synapsin I gene in primary cultures of differentiating rat cortical neurons

1995

Synapsin I is a neuron-specific protein which is present in two isoforms, Ia and Ib. In the last few years this protein has been demonstrated to play a central role in the regulation of neurotransmitter release and synaptic plasticity. In this paper the developmental expression of this protein has been investigated in primary neuronal cultures from fetal rat brain cortices. The presence of thyroid hormone in the culture medium stimulates an early expression of the protein without exerting any effect at the level of mRNA transcription and accumulation. These observations implicate a T3-dependent regulation of this neuron-specific gene at the level of mRNA translation. © 1995 Plenum Publishin…

Gene isoformmedicine.medical_specialtySynapsin ITime FactorsTranscription GeneticBlotting Westernsynapsin IGene ExpressionBiologyBiochemistryCellular and Molecular Neurosciencechemistry.chemical_compoundFetusInternal medicineSettore BIO/10 - BiochimicaGene expressionmedicineAnimalsRNA MessengerNeurotransmitterCells CulturedCell NucleusCerebral CortexNeuronsMessenger RNANeuroscience (all)Cell DifferentiationGeneral MedicineSynapsinBlotting NorthernSynapsinsthyroid hormoneRatsCell biologyKineticsmedicine.anatomical_structureEndocrinologynervous systemchemistryNeuronal differentiationSynaptic plasticityTriiodothyronineSettore MED/26 - NeurologiaNeuron
researchProduct

Peripheral nerve involvement in chronic liver disease. Clinical and electrophysiological study.

1986

A clinical and electrophysiological study was carried out on 19 selected patients with chronic liver disease. Clinical signs of peripheral nerve involvement were found in 4 patients (21%); while electrophysiological impairment was present in 11 patients (57.8%). These abnormalities were mostly limited to the sensory and motor fibers of the tibialis posterior nerve. Our data confirm the presence of peripheral nerve involvement in chronic liver disease, and that it may be evidenced by careful electrophysiological examination.

AdultLiver CirrhosisMalemedicine.medical_specialtyPathologyNeurologyNeural ConductionSensory systemDermatologyChronic liver diseasePeripheral nervemedicineHumansNeuroradiologyAgedHepatitis Chronicbusiness.industryGeneral NeuroscienceLiver DiseasesPeripheral Nervous System DiseasesGeneral MedicineMiddle Agedmedicine.diseasePsychiatry and Mental healthElectrophysiologyToxic neuropathyChronic DiseaseFemaleNeurology (clinical)NeurosurgerybusinessItalian journal of neurological sciences
researchProduct

Further evidence of genetic heterogeneity in familial essential tremor.

2007

Familial essential tremor (FET) is a common hereditary movement disorder with phenotypic variability and genetic heterogeneity. To date, linkage analyses revealed three loci associated to essential tremor (ET) (ETM1 on 3q13, ETM2 on 2p22-25, and a locus on 6p23). We performed a genetic analysis of these candidate chromosomal regions in a fifth-generation Italian kindred with autosomal-dominant ET. Of the 22 clinically evaluated family members, nine were affected by ET. The genetic study indicates that the ET in this family is not associated to any of the known ET loci. These findings support evidence of further genetic heterogeneity for such disease. (C) 2007 Elsevier Ltd. All rights reserv…

AdultMaleGenetic LinkageLocus (genetics)DiseaseBiologyGenetic analysisGenetic HeterogeneityGenetic linkagemedicineHumansAge of OnsetAgedGeneticsEssential tremorGenetic heterogeneityMiddle Agedmedicine.diseasePhenotypePedigreeNeurologySettore MED/03 - Genetica MedicaDisease ProgressionEssential tremorFemaleSettore MED/26 - NeurologiaNeurology (clinical)Geriatrics and GerontologyAge of onsetLinkage analysiNeurological disease
researchProduct

An exploration of anger phenomenology in multiple sclerosis

2009

Background and purpose:  Multiple sclerosis (MS) patients are often emotionally disturbed. We investigated anger in these patients in relation to demographic, clinical, and mood characteristics. Patients and methods:  About 195 cognitively unimpaired MS patients (150 relapsing–remitting and 45 progressive) were evaluated with the State Trait Anger Expression Inventory, the Chicago Multiscale Depression Inventory, and the State Trait Anxiety Inventory. The patients’ anger score distribution was compared with that of the normal Italian population. Correlation coefficients among scale scores were calculated and mean anger scores were compared across different groups of patients by analysis of …

business.industryMultiple sclerosismedia_common.quotation_subjectAngermedicine.diseasebehavioral disciplines and activitiesCorrelationMoodNeurologymental disordersbehavior and behavior mechanismsmedicineAnxietyNeurology (clinical)Analysis of variancemedicine.symptomPrefrontal cortexbusinesspsychological phenomena and processesState-Trait Anxiety InventoryClinical psychologymedia_commonEuropean Journal of Neurology
researchProduct

APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers

2006

Background: Previous studies have examined the role of APOE variation in multiple sclerosis (MS), but have lacked the statistical power to detect modest genetic influences on risk and disease severity. The meta- and pooled analyses presented here utilize the largest collection, to date, of MS cases, controls, and families genotyped for the APOE epsilon polymorphism. Methods: Studies of MS and APOE were identified by searches of PubMed, Biosis, Web of Science, Cochrane Review, and Embase. When possible, authors were contacted for individual genotype data. Meta-analyses of MS case-control data and family-based analyses were performed to assess the association of APOE epsilon genotype with dis…

Apolipoprotein EOncologyRiskmedicine.medical_specialtyPathologyMultiple SclerosisGenotypeApolipoprotein E2Apolipoprotein E4Polymorphism Single NucleotideSeverity of Illness IndexLinkage DisequilibriumPrimary progressiveCentral nervous system disease03 medical and health sciences0302 clinical medicineApolipoproteins EDisease severityPolymorphism (computer science)Internal medicineGenotypemedicineHumansGenetic Predisposition to Disease10. No inequalityAlleles030304 developmental biology0303 health sciencesExpanded Disability Status ScalePolymorphism GeneticScience & Technologybusiness.industryMultiple sclerosismedicine.disease3. Good healthPedigreePhenotypeCase-Control StudiesSettore MED/26 - NeurologiaNeurology (clinical)businessMultiple Sclerosis APOE disease severity meta-analysis030217 neurology & neurosurgery
researchProduct

DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex.

2005

Mutations in DJ-1 gene have been recently shown to cause autosomal recessive early-onset Parkinson’s disease (EOPD) in a large Dutch family and in a small consanguineous Italian family.1 Subsequent to this initial finding, several additional DJ-1 mutations were identified in subjects with EOPD.2–6 We describe a family from southern Italy with three brothers affected by a complex disorder characterized by early-onset parkinsonism-dementia-amyotrophic lateral sclerosis (EOPD-D-ALS). The analysis of the DJ-1 gene showed a novel homozygous mutation (E163K) in exon 7 and a novel homozygous mutation (g.168_185dup) in the promoter region of this gene in living affected subjects

MalePathologymedicine.medical_specialtyDNA Mutational AnalysisProtein Deglycase DJ-1Glutamic AcidGene mutationParkinsonismmedicine.disease_causeDISEASEPARK7GUAMExonMucoproteinsDegenerative diseaseParkinsonian DisordersmedicineHumansDementiaRNA MessengerAmyotrophic lateral sclerosisGeneFamily HealthOncogene ProteinsGeneticsMutationReverse Transcriptase Polymerase Chain Reactionbusiness.industryParkinsonismAmyotrophic Lateral SclerosisIntracellular Signaling Peptides and ProteinsExonsDEGENERATIONBlotting Northernmedicine.diseaseGENEINCLUSIONSNeurologyMutationAmyotrophic LateralFemaleDementiaNeurology (clinical)TAUbusiness
researchProduct

NEURONS AND ASTROCYTES SHED EXTRACELLULAR VESICLES THAT SEEM TO VEHICLE ANGIOGENIC FACTORS

2007

neuronsastrocytes extracellular vesicleangiogenic factors
researchProduct

Tumors preceding ALS onset and ALS: results from a case-control study.

2009

Amyotrophic Lateral Sclerosis Cancer Case-comntrol studySettore MED/26 - Neurologia
researchProduct

Determinants of depressive symptoms among spouse caregivers of patients with Parkinson's disease

2004

Parkinson
researchProduct

COGNITIVE IMPAIRMENT IN PATIENTS WITH PARKINSON’S DISEASE

2011

Settore MED/26 - NeurologiaCOGNITIVE IMPAIRMENTPARKINSON’S DISEASE
researchProduct

Brain cells shed angiogenic and/or pro-apoptotic factors by extracellular vesicles

2008

sheddingextracellular membrane vesiclebrain cell
researchProduct

A three-cell type in vitro-model of BBB

2005

BBB in vitro model brain cells
researchProduct

LEVITIRACETAM IN THE TREATMENT OF CREUTZFIELDT-JACOB DISEASE

2007

researchProduct

Studio delle frequenze alleliche di +1188 A/C di IL12B (p40) in soggetti affetti da Sclerosi Multipla.

2005

researchProduct

Sleep and sleepiness in Parkinson’s disease: result of a “spontaneous” observational study on rotigotine

2010

Settore MED/26 - Neurologiarotigotine sleep parkinson's disease
researchProduct

Clinical features and disease out come in patients with pediatric and young adult onset Multiple Sclerosis

2012

pediatric Multiple sclerosis young onsetSettore MED/26 - Neurologia
researchProduct

Depression and associated factors among spouse-caregivers of patient with Parkinson’s disease

2004

researchProduct

PREGNANCIES MODIFY RELAPSES AND PROGRESSION IN MULTIPLE SCLEROSIS

2014

Multiple sclerosisSettore MED/26 - Neurologia
researchProduct

Height as a potential indicator of early life events predicting Parkinson's disease: a case-control study.

2007

Aim of this study was to investigate the relationship between height in young adult age and Parkinson's disease (PD) risk. We included 266 persons affected by idiopathic PD. Patients were matched by age and sex to 266 controls by a random selection from the municipality of residence. We collected information about height preceding PD from official documents where these characteristics referred to young adult age (nearly 30 years). We compared height in cases and controls by calculating differences in mean distribution and by χ2 analyses. Crude and adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated by logistic regression models. Mean height was significantly lower in…

Dopamyne Electrochemical Techniques
researchProduct

BOTH NEURONS AND ASTROCYTES RELEASE EXTRACELLULAR VESICLES

2005

researchProduct

EFFETTO DI TERRENI CONDIZIONATI DA NEURONI ED ASTROCITI SULLE PROPRIETÀ BARRIERA DI CELLULE DEI CAPILLARI CEREBRALI.

2004

terreni condizionatiNeuroni astrociti cellule dei capillari cerebrali
researchProduct

Neurons and astrocytes shed extracellular membrane vesicles containing angiogenic factors

2009

Brain cells membrane vesicles angiogenic factors
researchProduct

Remarkably increasing incidence of Multiple Sclerosis. A follow-up study in calatanissetta, Sicily

2006

researchProduct

The HLA locus and multiple sclerosis in Sicily

2004

researchProduct

In vitro models of blood-brain barrier and application in the study of the multiple sclerosis

2008

in vitro modelSettore BIO/10 - Biochimicarat cortical neuronSettore MED/26 - Neurologiabrain cell culturemultiple sclerosisBBB
researchProduct

Primary Progressive and progressive relapsing multiple sclerosis show different clinical and instrumental findings and disability progression? A comp…

2013

Multiple Sclerosis Progression Sicilian databaseSettore MED/26 - Neurologia
researchProduct

First italian case with a de novo T666M mutation in the CACNA1A gene associated with hemiplegic migraine/progressive cerebellar and episodic ataxia

2004

researchProduct

INFLUENCE OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) ON ACTION TREMOR IN MULTIPLE SCLEROSIS PATIENTS

2014

rTMSMultiple sclerosiSettore MED/26 - Neurologiatremor
researchProduct

Natalizumab therapy of relapsing-remitting multiple sclerosis: an evaluation of the safety profile and a comparison of efficacy with interferon beta …

2010

Natalizumab therapy multiple sclerosisSettore MED/26 - Neurologia
researchProduct

Analisi dei Polimorfismi di Citochine Th2 nella Sclerosi Multipla.

2007

researchProduct

Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

2011

none 25 no Abstract OBJECTIVES: To evaluate the incidence and dose-dependency of mitoxantrone (MTX)-associated acute myelocytic leukemia (AML) in the network of Italian multiple sclerosis (MS) clinics. METHODS: We performed a multicenter retrospective cohort study of patients treated with MTX in MS centers under the Italian national health care system between 1998 and 2008. Demographic, disease, treatment, and follow-up information were collected using hospital records. RESULTS: Data were available for 3,220 patients (63% women) from 40 Italian centers. Follow-up (mean ± SD) was 49 ± 29 months (range 12-140 months). We observed 30 cases of AML (incidence 0.93% [95% confidence interval 0.60%…

Malemedicine.medical_specialtyMyeloidmitoxantrone; acute myelocytic leukemia; multiple sclerosisPopulationmultiple sclerosisStatistics NonparametricmitoxantroneFollow-Up StudieArts and Humanities (miscellaneous)Retrospective StudieInternal medicineMultiple SclerosimedicineHumansmultiple sclerosis leukemia mitoxantroneProspective cohort studyeducationRetrospective StudiesAgedAnalgesicseducation.field_of_studyMitoxantroneCumulative dosebusiness.industryMultiple sclerosisIncidence (epidemiology)leukemiaMyeloid leukemiaRetrospective cohort studymedicine.diseaseConfidence intervalSurgeryLeukemiaLeukemia Myeloid Acutemedicine.anatomical_structureItalyCohortSettore MED/26 - NeurologiaAnalgesicFemaleNeurology (clinical)acute myelocytic leukemiaMitoxantronebusinessFollow-Up Studiesmedicine.drugHuman
researchProduct

Polycistic ovary syndrome and antiepileptic drugs: a cross-sectional study

2005

researchProduct

Clinical features, disease course and prognosis in patients with paediatric and young adult onset multiple sclerosis

2013

Background. Multiple sclerosis (MS) patients develop their first symptoms before adolescence approximately in 5%. Studies comparing clinical and prognostic characteristics in early onset MS, did not show homogeneous results. Objective. Aim of this study was to investigate characteristics of early onset MS patients and compare them with patients who experienced MS onset later. Methods. MS patients diagnosed as affected by MS according to Poser's criteria, were included if they experienced symptoms onset before age 25. They were classified in three groups. Group A: patients who had their onset until they were 16 years old Group B: individuals with onset between 17 and 20 yearsGroup C: patient…

Settore MED/26 - NeurologiaPediatric Multiple Sclerosis Epidemiology Prognosis
researchProduct

Use of antiepileptic drugs in women with polycystic ovary syndrome

2005

polycystic ovary syndrome
researchProduct

Screening for PINK1 mutations in patients with early- and late-onset Parkinson's Disease

2005

researchProduct

SHEDDING OF ANGIOGENIC FACTORS BY BRAIN CELLS

2007

angiogenic factorsbrain cellsshedding
researchProduct

Levetiracetam, a new option Treatment for Creutzfeldt-Jacob Disease.

2007

LevetiracetamSettore MED/26 - Neurologia
researchProduct

A SPG4 GENE MUTATION CAUSES AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA IN AN ITALIAN FAMILY

2006

researchProduct

Lifestyle factors and multiple sclerosis: a case control study

2010

Multiple sclerosisSettore MED/26 - Neurologia
researchProduct

MRI abnormalities following repeated and incoming seizures

2006

Neuroimaging, an important diagnostic tool frequently used in the evaluation of patients with epilepsy, has mainly the aim to identify structural abnormalities needing a treatment and to contribute to the definition of the aetiology. Brain magnetic resonance imaging (MRI) in epilepsy is more sensitive than computerized tomography (CT) scan for detecting abnormalities. Status epilepticus (SE) and repeated incoming seizures may determine extensive and transient or long lasting pronounced MRI changes. We describe a case of a 41-year-old woman with a history of brain neoplasm, whose contrast-enhanced MRI images following repeated and incoming seizures were characterized either by reversible and…

researchProduct

Age at onset of parkinson's disease in women is associated with age at menopause.

2005

researchProduct

Sleep disturbances and dysautonomic dysfunction are associated in patients with Parkinson’s disease

2012

Parkinson's disease dysautonomic dysfunction sleep disturbancesSettore MED/26 - Neurologia
researchProduct

Hypoxanthine and purine compounds in plasma from patients with multiple sclerosis and psoriasis

2011

HypoxanthineSettore BIO/10 - BiochimicaPsoriasisMultiple sclerosiSettore MED/26 - NeurologiaHypoxanthine; Multiple sclerosis; Psoriasis
researchProduct

A post-marketing comparison study on disability modification in progressive multiple sclerosis after interferon beta-1b or mitoxantrone therapy

2006

researchProduct

Multiple sclerosis in southern Europe: Monreale City, Italy. A twenty-year follow-up incidence and prevalence study.

2004

BACKGROUND: Several follow-up studies showed increasing prevalence and incidence rates for multiple sclerosis (MS). OBJECTIVE:To ascertain, throughout a follow-up study, the incidence and prevalence of MS in the city of Monreale, Sicily, southern Italy. METHODS:We calculated crude and age- and sex-specific prevalence rates on December 31, 2000, and determined incidence rates for the period January 1, 1992 to December 31, 2000. RESULTS:The prevalence of MS was 71.2 per 100,000 population (48,5/100,000 in men; 93,0/100,000 in women). The incidence rate of MS for the period 1992-2000 was 4.0/100,000 per year. CONCLUSION:This study showed a nonsignificant increase in MS incidence rates in Monre…

AdultMaleMultiple SclerosisAdolescentIncidenceMiddle AgedCatchment Area HealthItalyPrevalenceHumansMultiple sclerosiFemaleChildSicilyAgedFollow-Up StudiesNeuroepidemiology
researchProduct

Frequency and determinants for hemorragic transformation of cerebral infarction

2006

researchProduct

PINK1 MUTATIONS AND THE RISK OF PARKINSON'S DISEASE IN FAMILY MEMBERS OF SOUTHERN ITALY

2007

researchProduct

Neutralizing antibodies in multiple sclerosis patients treated with 375 microg interferon-beta-1b.

2009

Multiple sclerosis interferon-beta-1bSettore MED/26 - Neurologia
researchProduct

Tumor diagnosis after PD onset: a case-control study

2004

researchProduct

Effect of the serum from multiple sclerosis patients on an in vitro model of blood-brain barrier.

2008

Multiple sclerosis (MS) is characterized by focal inflammatory demyelination, largely due to autoimmune responses against different components of the myelin sheet. It is also generally accepted that the pathogenesis of MS consists of inflammatory and neurodegenerative phases, where demyelination should produce partially reversible clinical deficits that can remit, due to limited remyelination, while axonal degeneration produces permanent non-remitting clinical damage. It is also assumed that nervous system inflammation is initiated by autoreactive, myelin-specific T cells that permeate the blood-brain barrier and trigger a series of events leading to tissue destruction. In addition to antib…

multiple sclerosiin vitro modelSettore BIO/10 - Biochimicaneuronal damageblood-brain barrierbrain cell culture
researchProduct

Multiple sclerosis survival: a population-based study in Sicily.

2010

Background and purpose: There are few population-based surveys on multiple sclerosis (MS) survival. To investigate MS survival in MS patients recruited during surveys conducted in Sicily. Methods: Multiple sclerosis patients identified during previous surveys were randomly matched to two referent subjects by residence, year of birth, and gender. Living status was obtained by municipality records (end of follow-up June, 30th 2007) and, for the deceased, date and causes of death were searched. Kaplan-Meier plots were used to calculate differences in mortality between MS patients and referent subjects. MS risks for mortality with 95% confidence intervals (CI) were also calculated. Results: We …

Multiple sclerosisMultiple sclerosis survival population-based study prognosisSettore MED/26 - Neurologia
researchProduct

FREQUENCY AND DETETRIMINANTS OF HEMORRHAGIC TRASFORMATION OF CEREBRAL INFARCTION

2008

Stroke hemorragic transformationSettore MED/26 - Neurologia
researchProduct

A CASE-CONTROL STUDY ON THE ASSOCIATION BETWEEN DIABETES AND PD

2007

researchProduct

Tumor diagnosis preceding Alzheimer’s disease: a case-control study

2011

Settore MED/26 - NeurologiaAlzheimer's disease tumor cancer
researchProduct

MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis

2008

Objective: To prospectively validate MRI activity and neutralising anti-interferon antibody (NAb) during the first 6 months of interferon β treatment as response indicators in multiple sclerosis (MS). Methods: Patients with relapsing–remitting MS were followed during the first 2 years of treatment. Neurological assessments were performed every 3 months or when a relapse was suspected. MRI scans performed at baseline and at 3, 4, 5 and 6 months after the start of treatment were assessed centrally for disease activity: new T2 or gadolinium enhancing T1 lesions. NAb were assessed using the MxA protein assay; positivity was defined as two consecutive titres ⩾20 NU/ml. We evaluated the predictiv…

MaleNeutralising antibodyMULTICENTERPLACEBO-CONTROLLED TRIALGUIDELINESGastroenterologyDOUBLE-BLINDInterferon βMAGNETIC-RESONANCEProspective StudiesNeurologic ExaminationbiologyBrainIMPAIRMENTMiddle AgedPredictive valueMagnetic Resonance ImagingRecombinant ProteinsPsychiatry and Mental healthTreatment OutcomeSettore MED/26 - NeurologiaFemaleAntibodyInterferon beta-1bAdultmedicine.medical_specialtyDIAGNOSTIC-CRITERIAInjections SubcutaneousAntibodiesDrug Administration ScheduleDisease activityMultiple Sclerosis Relapsing-RemittingAdjuvants ImmunologicNeutralization TestsInternal medicinemedicineHumansInterferon betabusiness.industryMultiple sclerosisDISABILITYMSInterferon-betamedicine.diseaseConfidence intervalSurgerybiology.proteinSurgeryNeurology (clinical)businessFollow-Up Studies
researchProduct

DOES MOTOR CORTEX HIGH FREQUENCY RTMS MODULATE INTRACORTICALINHIBITION IN PATIENTS WITH PARKINSON'S DISEASE ?

2006

researchProduct

ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION (TDCS) APPLIED TO THE MOTOR CORTEX AMELIORATES FREEZING OF GAIT IN PATIENTS AFFECTED BY PARKINSON’S DI…

2012

Background: Progression of Parkinson’s disease (PD) is frequently characterized by the occurrence of freezing of gait (FOG), which generally does not improve with dopaminergic therapy and with current available surgical therapies. Recent evidences show that motor symptoms may be ameliorated by means of non-invasive brain stimulation techiniques in PD (transcranial current direct stimulation, TDCS; repetitive transcranial magnetic stimulation, RTMS). Objective: To investigate the efficacy of anodal TDCS in the treatment of FOG in PD. Excitatory anodal tDCS was applied unilaterally to the motor and premotor cortices controlateral to the most affected leg. Methods: randomized, double-blind, sh…

Settore MED/26 - NeurologiaFreezing of gait Parkinsons'disease
researchProduct

Atherothrombotic Stroke: Plasmatic Modification Of Homocysteine and Other Thiols

2004

homocysteinestroke
researchProduct

Qual e' la percentuale dei pazienti con Malattia di Parkinson eleggibili per la stimolazione cerebrale profonda del subtalamo? Risultati di un questi…

2004

researchProduct

Grey matter and white matter atrophy in a large population of patients with multiple sclerosis: a 2 years follow-up study based on a fully automated …

2006

researchProduct

Height as a predictor of Parkinson’s disease: a case-control study.

2005

researchProduct

IMMUNOSUPPRESSANT TREATMENT AND CANCER RISK IN A COHORT OF PATIENTS AFFECTED BY MULTIPLE SCLEROSIS

2011

CANCER RISKSettore MED/26 - NeurologiaMULTIPLE SCLEROSIS
researchProduct

Long-term survival of Parkinson’s disease: a population-based case-control study.

2006

In a set of a population-based study, long-term survival of 59 prevalent PD patients was compared with that of individuals free of neurological diseases matched 1:2 by sex and age of enrolment. PD individuals, compared with reference subjects, showed a two-fold increased risk of death (OR 2.1; 95 % CI 1.4, 3.1). Among causes of death, pneumonia and cachexia were significantly more frequent among PD patients than among individuals free of neurological diseases. We confirmed in a long-term follow-up study an increased mortality among PD individuals compared with that of the general population.

Settore MED/26 - NeurologiaParkinson’s disease · mortality · prognosis · population-based study
researchProduct

Idiopathic Parkinson’s Disease and Associated Conditions: Results From a Case-Control Study

2005

researchProduct

LATE MORTALITY OF HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE

2012

Introduction. Hemorrhagic transformation (HT), a complication of ischemic stroke (IS) is supposed to influence patient’s prognosis. Aim of our study was to evaluate, in a hospital-based series of patients not treated with thrombolysis, the relationship between HT and late mortality. Methods. Mortality of individuals with spontaneous HT was compared to that of individuals without. Medical records of patients diagnosed with anterior IS during the period 2004-2006 were reviewed. Living status was obtained from the public record office of the municipality of Palermo or indirectly by telephone interview. Outcome measure was 90 days survival after IS onset. Kaplan-Meier estimates were used to con…

Hemorrhagic transformation mortalitySettore MED/26 - Neurologia
researchProduct

Modulation of action tremor by repetitive transcranial magnetic stimulation in multiple sclerosis patients

2014

Background: Patients affected by Multiple Sclerosis (MS) can show a tremor of their upper limbs, mostly during the performing of finalised action (action tremor) or at the maintaining of a position against gravity (postural tremor), as key clinical feature of their disease. Objectives: In order to reduce the tremor, patients underwent to repetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex of left hemisphere. Methods: Eight patients affected by a middle form of MS were enrolled into the study. A standard neurological examination was carried out and the individual degree of disability was established employing the Expanded Disability Status Score (EDSS). At EDSS pa…

Action tremor ripetitive transcranial magnetic stimulation Multiple SclerosisSettore MED/26 - Neurologia
researchProduct

Gender Effect on Parkinson’s disease

2009

Parkinson's diseaseSettore MED/26 - Neurologiawomen
researchProduct

Chronic acquired hepatocerebral degeneration or Parkinson Disease? A case report

2013

Parkinson diseaseSettore MED/26 - Neurologia
researchProduct

Drug-induced parkinsonism: Prevalence, clinical features and follow-up study in three Sicilian communities [1]

1996

NeurologySettore MED/26 - NeurologiaNeurology (clinical)
researchProduct

Determinants of depressive symptoms among spouse caregivers of patients with Parkinson’s disease

2004

researchProduct

Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans.

2006

By combining all the data available from the Genetic Analysis of Multiple sclerosis in EuropeanS (GAMES) project, we have been able to identify 17 microsatellite markers showing consistent evidence for apparent association. As might be expected five of these markers map within the Major Histocompatibility Complex (MHC) and are in LD with HLA-DRB1. Individual genotyping of the 12 non-MHC markers confirmed association for three of them — D11S1986, D19S552 and D20S894. Association mapping across the candidate genes implicated by these markers in 937 UK trio families revealed modestly associated haplotypes in JAG1 (p=0.019) on chromosome 20p12.2 and POU2AF1 (p=0.003) on chromosome 11q23.1.

Multiple sclerosisGenome screenLinkage disequilibriumMeta-analysiSettore MED/26 - NeurologiaJAG1POU2AF1
researchProduct

In vitro model of blood-brain barrier and application on the study of the multiple sclerosis.

2008

in vitro modelBBBmultiple sclerosis
researchProduct

Tumor diagnosis preceding Parkinson's disease: A case-control study

2004

Lower cancer risk in Parkinson’s disease (PD) patients compared to the general population has been reported. However, most of the studies were based on death certificates. We designed a case– control study to estimate the association of tumor preceding PD onset and PD. PD patients were matched by age and gender to PD-free individuals, randomly selected from the municipalities of residence of cases. Occurrence of tumors preceding PD onset was assessed through a structured questionnaire. Neoplasms were categorized as benign, malignant, or of uncertain classification, and endocrine-related or not. Odds ratios (OR) were calculated using conditional logistic regression and adjusted for tumor cat…

tumorParkinson’s diseaseepidemiology
researchProduct

Metanalisi degli studi su fattori di rischio ambientali nella sclerosi multipla

2006

researchProduct

Cigarette Smoking, coffee consumption and multiple sclerosis: a case-control study

2007

researchProduct

Che cos'è la Sclerosis Multipla

2006

researchProduct

EXTRACELLULAR FACTORS INVOLVED IN THE INDUCTION OF BLLOD-BRAIN BARRIER

2005

researchProduct

SHEDDING OF EXTRACELLULAR VESICLES FROM BRAIN CELLS

2006

extracellular vesiclesbrain cellsshedding
researchProduct

Dropped head as an unusual presenting sign of myastenia gravis

2006

researchProduct

Serum acid homocysteine, oxidative stress markers and vitamins in multiple sclerosis

2006

researchProduct

Cholesterol level and hemorrhagic trasformation after ischemic stroke

2009

CholesterolIschemic strokeHemorrhagic transformationRisk factor
researchProduct

Clinical Features and disease outcome in pt with pediatric and young adult onset multiple sclerosis

2012

multiple sclerosis
researchProduct

Environmental risk factors for Parkinson's Disease

2005

researchProduct

Familiarity for epilepsy among multiple sclerosis patients with seizures: a pilot case-control study.

2008

Multiple sclerosis epilepsy case-control studySettore MED/26 - Neurologia
researchProduct

Extracellular membrane vesicle shedding and the blood-brain barrier

2010

vesicle sheddingblood-brain barrier
researchProduct

Sleep quality in caregivers of Parkinson’s disease and Alzheimer’s disease patients and its relationship to quality of life

2010

Settore MED/26 - Neurologiasleep quity caregivers Parkinson's disease alzheimer disease
researchProduct

Bilateral ptosis and internuclear ophthalmoplegia in a case of bilateral thalamic and midbrain Infarct.

2008

Cerebro-vascular disease ophthalmoplegiaSettore MED/26 - Neurologia
researchProduct

A population-based survey on cognitive performance in Sicily. Cognitive impairment is modified by fertile life characteristics.

2009

Settore MED/26 - NeurologiaCognitive performancewomenpopulation-based survey
researchProduct

Clinical and instrumental predictors of efficacy of natalizumab therapy in the course of multiple sclerosis: a retrospective study from a single cent…

2013

Multiple sclerosis episodemiology disease courseSettore MED/26 - Neurologia
researchProduct

Frequency and determinants for hemorrhagic trasformation of cerebral infarction

2006

researchProduct

An unexpected association between intracranial hypotension and split cord malformation

2007

researchProduct

BODY MASS INDEX AND PARKINSON'S DISEASE: A CASE-CONTROL STUDY

2006

researchProduct

AN UNUSUAL ASSOCIATION OF MYASTHENIA GRAVIS (MG) AND PANCREATIC NEUROENDOCRINE TUMOR (PNET): A CASE REPORT

2014

Mystenia gravipancreatic tumorSettore MED/26 - Neurologia
researchProduct

PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY DURING TACROLIMUS THERAPY FOR LIVER TRANSPLANTATION

2007

researchProduct

Depression and associated factors among spouse-caregivers of patients with Parkinson’s disease.

2004

researchProduct

Frequency of Mitoxantrone related heart involvement in patients affected by Multiple Sclerosis

2010

mitoxantrone heart involvement multiple sclerosisSettore MED/26 - Neurologia
researchProduct

GENOTYPIC AND PHENOTIPIC FACTORS IN ISCHEMIC STROKE IN YOUNG ADULTS

2005

researchProduct

Multiple reversibile MR signals in course of Epstein-Barr virus encephalitis

2010

Settore MED/26 - Neurologiaepstein barr encephalitis multiple reversible MR
researchProduct

Multiple ring-enhancing brain lesions in a ghanaian patient: a case report

2012

ring-enhancing brain lesions
researchProduct

Tipi diversi di cellule cerebrali rilasciano fattori di crescita attraverso vescicole extracellulari.

2006

researchProduct

Studio delle frequenze alleliche del polimorfismo +1902A/G del gene IL4R in soggetti affetti da sclerosi multipla .

2006

researchProduct

ANALISI DELLA PERMEABILITÀ DI UNO STRATO DI CELLULE ENDOTELIALI DEI CAPILLARI CEREBRALI, CO-COLTIVATE CON NEURONI ED ASTROCITI.

2004

cellule endoteliali co-oltivate neuroniastrociti
researchProduct

Return of disease activity after natalizumab therapy discontinuation in patients with multiple sclerosis: frequency and clinical and instrumental pre…

2012

Settore MED/26 - NeurologiaMultiple sclerosis natalizumab therapy
researchProduct

DENTATO-RUBRAL PALLIDOLUYSIAN ATROPHY: CLINICAL AND GENETIC ANALYSIS OF A SICILIAN PEDIGREE

2010

DRPLA
researchProduct

NOVEL ROUTES OF CELL TO CELL COMUNICATIONS AMONG BRAIN CELLS

2006

cell comunicationsbrain cellsshedding
researchProduct

The sporadic and familial Creuzfeldt-Jacob disease in Palermo from 1996 to 2006: epidemiological, clinical and neurophysiologic characteristics.

2008

Creuzfeldt-Jacob diseaseSettore MED/26 - Neurologia
researchProduct

DYSAUTONOMIC DYSFUNCTION IN PARKINSON’DISEASE BY SCOPA-AUT SCALE

2012

...

Settore MED/26 - NeurologiaDYSAUTONOMIC DYSFUNCTION PARKINSON’DISEASE SCOPA-AUT SCALE
researchProduct

The Mini Mental State Examination (MMSE) for Cognitive Impairment in multiple sclerosis (ms): a two years Longitudinal study in 300 patients.

2008

Cognitive impairment multiple sclerosis longitudinal studySettore MED/26 - Neurologia
researchProduct

Idiopathic Parkinson's disease and diabetes: results from a case-control study.

2007

Parkinson Diabete
researchProduct

Levetiracetam in the Treatment of Creutzfeldt-Jacob Disease.

2007

Levetiracetam
researchProduct

Acute onset parkinsonism during leukoencephalopathy and CMV infection

2012

CMV infection: leukoencephalopathy
researchProduct

TREATMENT OF MULTIPLE SCLEROSIS WITH INTERFERON BETA IN CLINICAL PRACTICE: 2-YEAR FOLLOW-UP DATA FROM THE SOUTH ITALY MOBILE MRI PROJECT

2006

researchProduct

Extracellular vesicles isolated by cerebrospinal fluid as biomarkers of inflammation in multiple sclerosis and inflammatory neurological diseases.

2014

multiple sclerosimicrovesiclebiomarkerSettore MED/26 - Neurologiacerebrospinal fluid
researchProduct

Extracellular vesicles as vehicles of angiogenic factors in brain cell cultures

2007

researchProduct

General anaesthesia versus local anaesthesia for carotidsurgery (GALA): a multicentre, randomised controlled trial.

2008

Background The eff ect of carotid endarterectomy in lowering the risk of stroke ipsilateral to severe atherosclerotic carotid-artery stenosis is off set by complications during or soon after surgery. We compared surgery under general anaesthesia with that under local anaesthesia because prediction and avoidance of perioperative strokes might be easier under local anaesthesia than under general anaesthesia. Methods We undertook a parallel group, multicentre, randomised controlled trial of 3526 patients with symptomatic or asymptomatic carotid stenosis from 95 centres in 24 countries. Participants were randomly assigned to surgery under general (n=1753) or local (n=1773) anaesthesia between J…

carotid endarterectomy general anaesthesialocal anaesthesiaSettore MED/26 - Neurologia
researchProduct

Co-culture of rat brain cells as a tool for studying cell-cell interactions

2012

Brain capillary endothelial cells (BCECs) form the blood-brain barrier (BBB) in response to interaction with other brain cells (astrocytes, pericytes and neurons). BCECs are characterized by tight junctions (TJ), maturation and stabilization of which require different proteins, such as occludin. When co-cultured with astrocytes and neurons, BCECs were found to form a monolayer resembling the natural BBB: paracellular flux of dopamine and sucrose (i.e. compounds which are unable to cross the BBB in vivo) significantly decreased (1), while the transendothelial electrical resistance (TEER) increased. In these conditions, BCECs produced a larger amount of occludin and tended to localize it at t…

tight junctionSettore BIO/10 - Biochimicaaquaporin 4blood-brain barrierSettore BIO/06 - Anatomia Comparata E Citologiashedding vesicle
researchProduct

Neuronal factors secreted through unusual pathways are probably involved in blood brain barrier (BBB) formation

2004

researchProduct

FURTHER EVIDENCE OF GENETIC HETEROGENEITY IN FAMILIAL ESSENTIAL TREMOR.

2007

researchProduct

MYOCARDIAL 123I-METAIODOBENZYLGUANIDINE UPTAKE IN GENETIC PARKINSON’S DISEASE.

2007

researchProduct

PARKINSON’S DISEASE AND PARKINSON’S DISEASE FAMILIAL HISTORY. RESULTS OF A CASE-CONTROL STUDY

2011

PARKINSON’S DISEASE FAMILIAL HISTORYSettore MED/26 - Neurologia
researchProduct

PINK mutation and the risk of parkinson's disease in family members of southern Italy

2007

researchProduct

NEURONAL FACTOR SECRETED THROUGH UNUSUAL PATHWAYS ARE PROBABLY INVOLVED IN BLOOD BRAIN BARRIER (BBB) FORMATION.

2004

BBB neuronal factor brain cells
researchProduct

Reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura

2008

Settore MED/26 - NeurologiaLeukoencephalopathy thrombocytopenic purpura
researchProduct

Mitochondrial DNA TRNACYS mutation in a family with frontotemporal dementia and Parkinson’s disease

2010

TRNACYS mutation frontotemporal dementia Parkinson's diseaseSettore MED/26 - Neurologia
researchProduct

Novel routes of cell to cell communications among brain cells

2006

researchProduct

EXTRACELLULAR FACTORS INVOLVED IN THE INDUCTION OF BLOOD BRAIN BARRIER (BBB)

2005

extracellular factorsBBBbrain cells
researchProduct

Predictors of caregiver burden in partners of patients with Parkinson's disease

2009

Parkinson's DiseaseSettore MED/26 - Neurologiacaregiver
researchProduct

CARATTERIZZAZIONE DI NUOVI MARCATORI MOLECOLARI NELLA SCLEROSI MULTIPLA: UN APPROCCIO PROTEOMICO

2007

researchProduct

A Door-to-Door population based survey on cognitive performance In Bagheria, Sicily.

2008

Settore MED/26 - NeurologiaCognitive performances population-based survey
researchProduct

Effetto dei terreni condizionati da neuroni ed astrociti sulle proprietà barriera di cellule di capillari cerebrali.

2004

researchProduct

Frequency and Determinants for Hemorrhagic Transformation of Cerebral Infarction

2007

researchProduct

Frequency of cognitive impairment and factors associated in outpatients with Parkinson’s disease

2011

cognitive impairment Parkinson diseaseSettore MED/26 - Neurologia
researchProduct

Metodo e kit per la sclerosi multipla

2011

E’ descritta la scoperta di anticorpi anti-transferrina come biomarcatori per la sclerosi multipla da cui è stato messo a punto un metodo di diagnosi, prognosi, monitoraggio della terapia e relativo kit.

ProteomicaAnti-transferrinaSettore BIO/13 - Biologia ApplicataAutoanticorpiKit DiagnosticoSclerosi Multipla
researchProduct

Implications for Estrogens in Parkinson’s Disease

2006

Evidence from experimental and epidemiological studies suggests a role of sex hormones in the pathogenic process leading to neurodegenerative diseases, (i.e., Alzheimer's and Parkinson's disease). The effects of sexual steroid hormones are complex and vary with the events of women's fertile life. Estrogens are supposed to influence dopamine synthesis, metabolism, and transport; however, there is no consensus regarding the direction, locus, and mechanism of the effect of estrogens on the dopaminergic system. A neuroprotective effect of estrogens has been demonstrated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-animal models of Parkinson's disease (PD). Epidemiological studies indi…

Settore MED/26 - NeurologiaAge at menopause Parkinson's disease
researchProduct

Introduzione alla neuroepidemiologia

2007

researchProduct

Gender-related effect of clinical and genetic variables on the cognitive impairment in MS.

2004

researchProduct

Angiogenic and/or pro-apoptotic factors are shed from brain cells via extracellular vesicles

2008

We set a three-cell type coculture system in which neurons and astrocytes synergistically induce brain capillary endothelial cells to form a monolayer with permeability properties resembling those of the physiological blood-brain barrier (BBB) (Schiera et al., 2003; Schiera et al., 2005). On the basis of immunofluorescence, scanner electron microscopy and western blot analyses, we also suggested that both astrocytes and neurons in culture shed extracellular vesicles that contain FGF-2 and VEGF, as well as beta1-integrin, a membrane protein that can be considered a marker of shedding (Schiera et al, 2007; Proia et al., 2008). In addition, it was already known that transformed glial cells (ol…

membrane vesicle sheddingSettore BIO/10 - BiochimicaFGF-2TRAILTGF-betaVEGF
researchProduct

The risk of disease worsening according to the length of exposure to IFNb in multiple sclerosis

2005

multiple sclerosis
researchProduct

LEPROSY: A CASE REPORT FROM SICILY, ITALY

2009

...

LEPROSYSettore MED/26 - Neurologia
researchProduct

RISK FACTORS FOR DYSKINESIAS IN PATIENTS WITH PARKINSON'S DISEASE

2011

DYSKINESIASSettore MED/26 - NeurologiaPARKINSON'S DISEASE
researchProduct

Genotypic and phenotypic factors in ischemic stroke in young adults

2005

researchProduct

remarkably increasing incidence of multiple sclerosis. A follow-up study in Caltanissetta, Sicily

2006

researchProduct

Clinical and Instrumental Findings and Disability Progression in Primary Progressive and Progressive Relapsing Multiple Sclerosis: A Comparison Study…

2013

Primary Progressive Multiple Sclerosis Progressive relapsing multiple sclerosisSettore MED/26 - Neurologia
researchProduct

Prevalence of comorbidity in Parkinson’s disease: a case-control study

2004

researchProduct

Purine metabolism and multiple sclerosis: pattern varies according to disease stage and clinical form

2013

multiple sclerosis purine metabolism
researchProduct

Quality of Care and Cost-Effectiveness of ALS Interdisciplinary Centers: The Quac Study

2006

researchProduct

Clinical and instrumental predictors of efficacy of Natalizumab therapy in multiple sclerosis patients: a retrospective study from a single centre

2012

Natalizumab Multiple sclerosisSettore MED/26 - Neurologia
researchProduct

Novel ways of cell-to-cell communications among brain cells

2007

researchProduct

HOMOZIGOUS DJ-1 MUTATION IN A FAMILY FROM SOUTHERN ITALY WITH AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM-DEMENTIA COMPLEX

2004

researchProduct

EFFECT OF SERA FROM PATIENTS WITH MULTIPLE SCLEROSIS ON A BLOOD-BRAIN BARRIER IN VITRO MODEL.

2009

BLOOD-BRAIN BARRIERIN VITRO MODELMULTIPLE SCLEROSIS
researchProduct

Height as an indicator of early life events predicting Parkinson's disease: a case-control study.

2006

researchProduct

Risk of Parkinson’s disease in women: effect of reproductive characteristics on the age at onset

2004

researchProduct

The Italian Natalizumab Registry: A 1-Year Follow-Up

2008

Natalizumab Multiple SclerosisSettore MED/26 - Neurologia
researchProduct

SERUM URIC ACID, HOMOCYSTEINE, OXIDATIVE STRESS MARKERS AND VITAMINS IN MULTIPLE SCLEROSIS.

2006

researchProduct

MORTALITY IN MULTIPLE SCLEROSIS. A POPULATION-BASED APPROACH

2007

researchProduct

AN IN VITRO MODEL OF BLOOD BRAIN BARRIER (BBB).

2005

in vitro modelBBBbrain cells
researchProduct

AN UNESPECTED ASSOCIATION BETWEEN INTRACRANIAL HYPOTENSION AND SPLIT CORD MALFORMATION

2007

researchProduct

FIRST ITALIAN CASE WITH A DE NOVO 7666M MUTATION IN THE CACNA1A GENE ASSOCIATED WITH HEMIPLEGIC MIGRAINE/PROGRESSIVE CEREBELLAR AND EPISODIC ATAXIA

2004

researchProduct

In vitro models of BBB: a tool for the analysis of cell to cell communication in the brain

2008

Many researchers have been trying to set in vitro models of the blood-brain barrier (BBB) aimed at analyzing, in simplified terms, the molecular mechanisms responsible for formation, maintenance and functioning of the BBB, as well as the capability of specific drugs and pro-drugs to cross BBB. We did it, starting with a simpler system of co-culture that allowed us to analyze the effects of neurons on differentiation of brain capillary endothelial cells (RBE4.B cells) in culture, and setting then a more complex model, that includes three cell types (endothelial cells, neurons and astrocytes). The reciprocal geometrical organization of brain cells in this model system is similar to the one ob…

extracellular membrane vesicleSettore BIO/10 - Biochimicacell-to-cell communicationin vitro models BBB
researchProduct

Rey-Osterrieth Complex figure performance in patients with degenerative dementia using Boston Qualitative Scoring System

2013

Settore MED/26 - NeurologiaRey-Osterrieth Complex figure dementia
researchProduct

Ruolo degli estrogeni nella malattia di Parkinson

2007

Malattia di Parkinson estrogeniSettore MED/26 - Neurologia
researchProduct

Heart involvement in patients treated with mitoxantrone for multiple sclerosis

2010

Settore MED/26 - NeurologiaMitoxantrone multiple sclerosis
researchProduct

DYSAUTOMIC DISFUNCTON OCCURS EARLY IN PARKINSON DISEASE

2011

Settore MED/26 - NeurologiaDYSAUTOMIC DISFUNCTONPARKINSON DISEASE
researchProduct

THE OPTIMIZATION OF INTERFERON FOR MS STUDY: 375 MICROG INTERFERON BETA-1B IN SUBOPTIMAL RESPONDERS.

2008

We aimed to evaluate the safety and MRI efficacy of interferon beta-1b (IFNbeta-1b) 375 microg (subcutaneously [sc] every other day [eod]) in relapsing-remitting multiple sclerosis (RRMS) patients with a suboptimal response to IFNbeta-1b 250 microg, i.e., with MRI activity or relapses. The OPTimization of Interferon for MS (OPTIMS) study was a prospective multicenter randomized phase 2 trial comprising a 6-month run-in phase (to identify suboptimal responders) and a 6-month randomized phase of open-label clinical and blinded MRI follow-up. During run-in all patients were treated with IFNbeta-1b 250 microg sc eod; during the study phase suboptimal treatment responders were randomized either …

Adultmedicine.medical_specialtyTime FactorsAdolescentInjections Subcutaneoussuboptimal treatment responseGastroenterologyDrug Administration Schedulelaw.inventionYoung AdultMultiple Sclerosis Relapsing-RemittingAdjuvants ImmunologicRandomized controlled triallawInternal medicinemedicineHumansSingle-Blind MethodProspective StudiesAdverse effectProspective cohort studyinterferon beta (IFNβ)immunomodulatory drugSubclinical infectionDose-Response Relationship Drugbusiness.industryInterferon beta-1bInterferon-betaMiddle AgedMagnetic Resonance ImagingConfidence intervalSurgeryClinical trialTreatment OutcomeNeurologyRelative riskmultiple sclerosiMRI activitySettore MED/26 - NeurologiaNeurology (clinical)businessFollow-Up StudiesInterferon beta-1b
researchProduct

FOLLOW-UP DI ALCUNI CASI DI ATROFIA DENTATO RUBRO PALLIDO LUISIANA PROVENIENTI DA UN'AREA CIRCOSCRITTA DELLA PROVINCIA DI TRAPANI

2005

researchProduct

A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis

2002

Objective - To investigate the efficacy of two different high doses of intravenous methylprednisolone (IVMP) during Multiple Sclerosis (MS) relapses. Background - Transcranial Magnetic Stimulation (TMS) is the most sensitive neurophysiological ascertainment to quantify motor disability, to follow the recovery from an MS relapse, and to detect the response to treatment. Design and method - Twenty-four clinically definite relapsing - remitting MS patients presenting a relapse were randomly assigned to a treatment for 5 days with IVMP 1 or 2 g/day. The response to treatment of each patient was evaluated through Expanded Disability Status Scale (EDSS), Medical Research Council (MRC) score, and …

Neuroscience (all)High dose methylprednisoloneMultiple sclerosiSettore MED/26 - NeurologiaNeurology (clinical)Randomized trialTranscranial magnetic stimulation
researchProduct

Frequency of John Cunningham virus (JCV) DNA and of antibodies against JCV in patients affected by multiple sclerosis and their relationship with nat…

2012

JCV virus Natalizumab Multiple SclerosisSettore MED/26 - Neurologia
researchProduct

Purine metabolism and Multiple Sclerosis: different pattern according to different disease stage and different clinical form.

2013

P422 Purine metabolism and multiple sclerosis: pattern varies according to disease stage and clinical form G. Salemi, M. Gueli, V. Cusimano, M. Lo Re, V. Lo Re, M.A. Mazzola, S. Realmuto, P. Ragonese, G. Savettieri University (Palermo, IT) Background: Serum concentration of uric acid (sUA) was variably associated with Multiple Sclerosis (MS). Many papers reported lower sUA in MS patients respect to healthy controls, expecially in course of relapse. This lower sUA was considered as a marker of oxidative stress. However, this association was not confirmed by many other papers. Recently, an increase in the concentration of sUA, hypoxanthine, xanthine, and sum of oxypurine (sPU) was reported in…

Multiple SclerosisPurine metabolismSettore BIO/10 - BiochimicaSettore MED/26 - Neurologia
researchProduct

Dropped head as an unusual presenting sign of myasthenia gravis

2006

researchProduct

Relationshiop between brain atrophy and lesion load and fatigue in multiple sclerosis

2005

researchProduct

A case control study to evaluate the relationship between cigarette smoking or coffee consumption and multiple sclerosis

2007

researchProduct

Shedding of extracellular membrane vesicles from brain cells in culture

2009

membrane vesiclebrain cell
researchProduct

Mortality of multiple Sclerosis: a population based study.

2008

Multiple sclerosis mortality population-based surveySettore MED/26 - Neurologia
researchProduct

Stress ossidativo e neurodegenerazione.

2005

researchProduct

Cholesterol level and hemorrhagic transformation after ischemic stroke

2009

Strokehemorrhagic transformationcholesterolSettore MED/26 - Neurologia
researchProduct

A CASE OF JUVENILE STROKE CAUSED BY ACTINIC CERVICAL ARTERIOPATHY

2013

Introduction: Radiation Arteriopathy is a vascular disease characterized by progressive arterial stenosis that may occur after external radiotherapy (RT) directed to a specific body region affected by malignant tumours. The arterial damage usually starts many years after the injury and the specific pathogenesis is unknown, though atherosclerosis praecox, endothelial damage, adventitial fibrosis and vasa vasorum obliteration are likely involved mechanisms. In patients with previously irradiated neck or head cancers, supra aortic arteries can be affected in their segments exposed to radiations leading to a gradual lumen narrowing. This late complication leads to a progressive stenosis of extr…

acute juvenile strokeRadiation Arteriopathy
researchProduct

How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a screening questionnaire.

2004

researchProduct